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ABSTRACT OF DISSERTATION
MAPPING OF THE CHROMIUM AND IRON PYRAZOLATE LANDSCAPE
by
Jessica María López Plá
Florida International University, 2018
Miami, Florida
Professor Raphael G. Raptis, Major Professor
The main objective of this project is to synthesize the first family of polynuclear
chromium pyrazolate complexes. Complexity in analysis of the experimental magnetic
data of multinuclear complexes arises from their (2S +1)N microstates, where S is the spin
of each metal center and N is the number of metal centers. For example, high-spin (HS)FeIII3 has 216 microstates and HS-FeIII8 ≈ 1.7x106 microstates (S= 5/2). However,
complexes with chromium(III) S = 3/2 will have a noticeable reduction of microstates.
Mononuclear complexes with formula [mer-CrCl3(pzH*)3] (pz*H = pyrazole, 3-Me-pzH,
4-Me-pzH, 4-Cl-pzH, 4-I-pzH, 4-Br-pzH) and [trans-CrCl2(pzH*)4]Cl (pzH* = pyrazole
and 3-Me-pzH) were synthesized and thoroughly characterized. Polynuclear iron
pyrazolate complexes are prepared by the addition of base to [mer-FeCl3(pzH*)3] and
[trans-FeCl2(pzH*)4]Cl complexes; the path is not paralleled by mononuclear
chromium(III) pyrazole complexes. There is a challenging situation with these reactions,
caused by the attainment of equilibrium, where the stable mononuclear complexes and
traces of dinuclear species coexist in solution. Microwave assisted reaction of
Cr(NO3)3·9H2O and pyrazole ligand in dimethylformamide (DMF) solution afforded
redox inactive trinuclear formate-pyrazolate mixed-ligand complexes with formula
vii

[Cr3(μ3-O)(μ-O2CH)3(μ-4-R-pz)3(DMF)3]+ (pz = pyrazolate anion; R= H, Me, Cl).
Thermally assisted synthesis with non-hydrolysable solvent yielded an electrochemically
active all-pyrazolate complex. Complex with formula (Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Cl3]
and (Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Br3] have an oxidation process at 0.502 V at 0.332 V,
respectively. The latter has a second accessed oxidation process at 0.584 V. These
systems are the first example of electrochemically amendable trinuclear pyrazolate
complex with {Cr3O} core.
The all-ferric complexes [Fe3(μ3-O)(μ-4-NO2-pz)6(L)3]2- (L = NCO-, N3) were
synthesized from reaction of [Fe3(μ3-O)(μ-4-NO2-pz)6Cl3]2- with NaNCO and NaN3.
Expected reversible reduction processes were observed for both complexes at more
negative potential, -0.70 V, compared to the thiocyanate complex (-0.36 V). The

57

Fe

Mössbauer of the reduced [Fe3(μ3-O)(μ-4-NO2-pz)6(N3)3]3- is suggestive of a HS-to-LS
electronic reorganization, as seen for the [Fe3(μ3-O)(μ-4-NO2-pz)6(SCN)3]3- complex.
Furthermore, compound [Fe3(μ3-O)(μ-4-NO2-pz)6(N3)3]2-, shows a unique reversible
oxidation process at 0.82 V (vs. Fc+/Fc) to a mixed-valent, formally Fe3+2/ Fe4+ species.
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Chapter 1: Introduction

1.

Metal oxides
The study of complex mechanisms pertinent to metal oxide structures, have

become a wide and interesting subject, because of their diverse applications. Metal oxides
have become commercially important because their applications range from their use in
surgical implants in a medicinal context (e.g., tungsten and zinc oxides), 1 antimicrobial
agents in an ecological context (e.g., iron and titanium oxides),2,3 information storage in
electromagnetic devices (e.g., ferromagnetic iron oxides),4 and catalysis.5
1.1.

Metal oxides in biological systems
Metal oxides participate in biochemical reactions as electron transfer agents. For

example, anaerobic bacteria, such as G. sulfurreducens, use FeIII oxides as electron
acceptors in their metabolism.6 The mechanism of electron transfer (ET) classifies these
processes into two categories: inner sphere (IS) and outer sphere (OS) transfer. In the
ISET there is a covalent linkage between the reductant and oxidant. Therefore, ISET is
rarely observed in biological systems, where the long-range ET between redox active
sites is often shielded by bulky proteins.7 The OSET occurs between species that remain
spatially separated before, during and after the electron transfer. The OSET is at the basis
of biological function of iron-sulfur proteins, such as ferrodoxins.8

1

Figure 1. Reduction and oxidation mechanism in the Fe4S4-unit of ferredoxins.8

1.2.

Classification of mixed-valence cases
The events of electron donation or acceptance often lead to mixed-valence

compounds, in which the oxidation state varies among the metal atoms. The classification
of mixed-valent compounds is time-dependent -it depends on how the electron-transfer
rate compares to the corresponding timescale of the spectroscopic technique used to
monitor the process- in the case of the Robin-Day classification, UV-VIS-NIR
spectroscopy.9,10 For example, a system that appears to be delocalized by a slow
technique may appear as localized by a faster one. Mixed-valent compounds are
subdivided into three groups, according to the Robin-Day scheme, as Class I, Class II and
Class III, in which the valences are localized, partially delocalized or completely
delocalized, respectively (Figure 2).11 In Class II and Class III compounds, different
magnetic properties are observed, depending on the extent of charge delocalization. The
factors that determine whether a mixed-valence complex will belong to Class I, II, or III
are not well understood in polynuclear complexes. The charge introduced in an metal
oxide lattice (such as an iron oxide lattice) polarizes neighbor atoms and causes
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distortions in the local structure.12 The charge and its accompanying distortion are called
a polaron (Scheme 1). A polaron can be localized or delocalized over several metal
centers, stationary or mobile, the latter being the case of electrically conducting oxides.13

Figure 2. Potential energy diagram for Class I, Class II and Class III species according to
the Robin-Day Scheme. Modified from reference 11 .

Scheme 1. Small polaron in iron oxide showing the local structural distortion created by
the reduction of an FeIII (orange) site to FeII (red).13
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1.3.

Metal oxide models
The understanding of metal oxide properties in nature has been possible from

modeling such systems by polynuclear clusters. Synthetic metal clusters have been
reliable models for metalloenzyme active sites.14,15 Metal cluster model studies provide
fundamental insight to the enzyme active site geometries, electronic structures and
reaction mechanisms.16,17 Synthesis of polynuclear clusters that mimic metalloenzyme
active site structures have been reported with multiple bridging ligands, such as Schiff
base, oximes, imidazole, carboxylate and pyrazolates.18–21
1.4.

Iron complexes as active site models
Carboxylate-bridged diiron active sites are found in many metalloproteins listed

in Table 1.17,22 Numerous studies have utilized basic carboxylate, formate and acetate
ligands to mimic the amino acid side chains found at the metalloprotein active sites. The
first synthetic model of the reduced state of hemerythrin is [Fe2(μ-OH)(μ-OAc)2(Me3TACN)2]+, depicted in Figure 3.23

Figure 3. Active site of hemerythrin (left) and its synthetic model (right).17
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Table 1. Identified and characterized diiron metalloproteins. Modified from Tshuva et
al.17
Enzyme
alkene monooxygenase
butane monooxygenase
DMQ monooxygenase
ferritins
hemerythrin
methane monooxygenase
phenol hydroxylase
purple acid phosphotase
ribonucleotide reductase
rubrerythrin
toluene nonooxygenases
Δ9 desaturases
ω-alkane hydroxylase
1.5.

Function
alkene epoxidation
butane oxidation to alcohol
quinone generation
iron storage
dioxygen carrier
methane to methanol oxidation
phenol to catechol oxidation
phosphate ester hydrolysis
tyrosyl radical generator
putative peroxidase
toluene to cresol oxidation
alkane conversion to alkene
alkane oxidation to alcohol

Polynuclear complexes of interest
Remarkable studies on pyrazole coordination chemistry have been developed

since the late 1970's,18,21,24 and pyrazolate complexes have been proven to be good models
of metalloprotein active sites.25 Furthermore, biological activity and therapeutic
properties have been reported for pyrazole containing compounds.26,27
Pyrazoles are heterocyclic aromatic rings consisting of three carbon atoms and
two vicinal nitrogen atoms (in positions 1 and 2, Scheme 2). After deprotonation of N1,
pyrazoles act as monodentate or bidentate ligands. The electronic properties of the
pyrazole are mainly influenced by the substituent at the 3-, 4-, and 5-position, whereas,
steric properties are influenced only by the 3- and 5-position substituents. The
coordination versatility of pyrazoles is depicted in Scheme 3. The coordination ability of
the pyrazole ligand depends on the nature of the metal and of the substituents of the
carbon atoms on the aromatic ring.28
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Scheme 2. Substituent positions on pyrazole ligand (pzH).

Scheme 3. Coordination modes of pyrazoles (pzH) and pyrazolates (pz).28

6

1.5.1. Trinuclear carboxylate and pyrazolate complexes
Carboxylate ligands have been broadly compared with the pyrazolate ligands, as
there are some structural analogies between complexes of these ligands, even though they
differ in their rigidity (Scheme 4) and reactivity.29 Different nuclearity pyrazolate and
carboxylate complexes have similar M···M distances, summarized in Table 2.

Scheme 4. Structural comparison between pyrazolate and carboxylate bridging modes.

Palladium trimers, with formula [PdII(µ-OCOR)2]3 and [PdII(µ-pz*)2]3 (pz* = pz
and 3-Ph-pz) and square planar metal centers, share similar metal-metal distances and
luminescent properties.29,30 In trinuclear complexes, octahedral metal centers are bridged
by an axial μ3-O atom, six bidentate ligands occupying the equatorial sites of the metals,
the three terminal ligands. Within the isolateral triangle of the [CoIII3(μ3-O)(μ-4-NO2pz)6(NO2)3]2- complex, the Co···Co distances (Table 2) are significantly shorter than
those of the analogous carboxylate [CoIII3(μ3-O)(μ-RCOO)6L3]+1, (L= neutral ligand like
H2O, MeOH or py).31 In complexes containing iron, the [FeIII3(μ3-O)(μ-4-NO2-pz)6X3]2(X = Cl, Br and NCS) the FeIII3(μ3-O)-core is structurally indistinguishable from the
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analogous carboxylate [FeIII3(μ3-O)(μ-O2CR)6L3]+ (L = neutral ligand, such as H2O,
MeOH and py)32; they only differ in their magnetic properties, as a result of structural
differences from the bridging ligands.32–35

Figure 4. Trinuclear PdII complexes with μ-pz (left) and μ-O2CR (right) ligands.29,36

Table 2. M···M distances (Å) for pyrazolate and the analogous carboxylate complexes.
Compound

Distance

[Fe (μ -O)(μ-4-NO -pz) Cl ]
3

3

2

6

2-

3.267(1), 3.280(1)

3

[Pd3(μ-pz)6]

3.0471 (126)

[Co (μ -O)(μ-4-NO -pz) (NO ) ]
3

3

Compound

2

6

2 3

2+

29

33

Distance

[Fe (μ -O)(μ-O CPh) (py) ]
3

3

2

6

[Pd3(μ-O2R)6]

3.0878(9), 3.0985(9), [Co (μ -O)(μ-O Ac) py ]
31
3 3
2
6
3
3.1073(9)

3

+

3.306(1)

32

3.131(1)-3.191(1)
3.194(1)

36

37

With regard to their substitution kinetics, carboxylate complexes of platinum,
rhodium and ruthenium, range from moderately to highly labile, showing potential as
homogeneous catalysts.38 On the other hand, the lability of carboxylate complexes is a
problem for the study of their redox activity, as they readily decompose. The relative
inertness of the pyrazolates gives these complexes a significant advantage for
electrochemical studies.
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Redox properties of trinuclear complexes with formula [Fe3(μ3-O)(μ-4-NO2pz)6X3]2- (X = Cl, Br, NCS) show one electron reversible reduction and a second
irreversible reduction, where the potential is strongly dependent on the electron donating
and/or withdrawing properties of the terminal ligand.33–35

Figure 5. Ball-and-stick representation of [Fe3(μ3-O)(μ-4-NO2-pz)6Cl3]2-.33

Figure 6. Cyclic voltammogram of (TBA)2[Fe3(μ3-O)(μ-4-NO2-pz)6Cl3] vs. Fc+/Fc.33
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1.5.2. Octanuclear carboxylate and pyrazolate complexes
The synthesis of an octanuclear chromium(III) carboxylate complex with formula
[Cr8(4-O)4(-O2CPh)12(O2CPh)4] has been achieved via a thermal treatment route. All
Cr centers are in an octahedral environment.39 A magnetic susceptibility study concluded
that an antiferromagnetic exchange operates among the Cr centers, with exchange
parameters J1= -2.1.0 cm-1 and J2 = -3.4 cm-1 representing the exchange between the Cr
atoms within the central heterocubane and the exchange between central and outer Cr
centers, respectively.39 However, redox modification of this Cr8 complex to achieve
mixed-valence CrIII/IV or CrII/III species has not been reported to date, possibly because of
the well-known lability of carboxylate complexes, which may only cause irreversible
redox processes.

Figure 7. Structure of [Cr8(μ4-O)4(μ-O2CPh)12(O2CPh)4]. H-atoms are omitted for clarity.
(Cr, pink; O, red; C, black)39
10

An analogous structure to the Cr8 carboxylate complex has been synthesized, with
the general formula [Fe8(μ4-O)4(4-R-pz)12X4] (pz = pyrazolate anion, C3H3N2).40 These
complexes have an Fe8O4 motif in the core surrounded by twelve bridging pyrazolate and
four terminal ligands. They are structurally analogous to the Fe8O4 motif that constitutes
minerals, such as magnetite (Fe3O4), maghemite (ɣ-Fe2O3), and ferrihydrite, when
repeated in three dimensions. The magnetic and electrical properties of these minerals
have led to several applications.41 The variation of the 4-position substituent (R) in the
pyrazole with R = Me, Et, Ph, CH2CH2Cl, CH2CH2OH, Cl, Br and I, and the terminal
ligand X = NCS, OAr, N3, NCO, Cl, and Br, give rise to similar behavior with regard to
their redox and magnetic properties.

Figure 8. Ball-and-stick representation of [FeIII8(μ4-O)4(μ-pz)12Cl4] (Fe, brown; Cl, green;
O, red; N, blue; C, black).40
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Figure 9. Structure of Fe8O4 core of the [FeIII8(μ4-O)4(μ-pz*)12X4].

The electrochemical study of [Fe8(µ4-O)4(µ-pz)12Cl4] showed four reversible
reduction processes at -0.43 V, -0.78 V, -1.07 V and -1.38 V (vs. Fc+/Fc). These redox
potentials change with the variation of the terminal ligands and the substitution of the
pyrazolate ligands. The narrower potential window of the above processes compared to
the corresponding analogous sulfur structures, for example, Fe4S4 cubanes found in
ferrodoxins, suggests that these oxo-centered iron cores are more efficient electron
transfer agents. The superior electron transfer properties of the Fe4O4 core provides
evidence of the existence of four reduced states beyond the neutral all-ferric complex and
also suggests the possible existence of these cores in nature.40
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Figure 10. Cyclic voltamogram of [FeIII8(μ4-O)4(μ-pz)12Br4] in 0.5 M TBAPF6/DCM, Ptdisk working electrode, vs. Fc+/Fc. Reproduced from Baran et al.40
,

Also, previous computational analysis of the magnetic susceptibility of these
Fe4O4-core complexes has revealed antiferromagnetic coupling between the iron centers
within the cubane core, which are mediated by the oxo-bridges, and a stronger coupling
between the inner (octahedral) and outer iron (trigonal bipyramidal) centers, with
coupling parameters J1/hc = -2.1 cm-1 and J2/hc = -50.6 cm-1, respectively, similar to the
proposed scheme for [Cr8].40
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1.5.3. Dinuclear carboxylate and pyrazolate complexes
Dinuclear chromium carboxylates were first introduced as "CrC4H4O5" by Peligot
more than a century ago.42 The complex is identified now as [Cr2(O2CCH3)4(H2O)2] with
2.362(1) Å Cr···Cr distance, indicative of a metal-metal interaction.43 Chromium
complexes with metal-metal bonds are subject of experimental and theoretical
investigation, because their multiple bonds can give insight in the metal-metal bonding
theory.44 Reported Cr···Cr distances range from 1.74 to 2.69 Å, for quintaply to singly
bonded species, respectively.45–48

Scheme 5. Structure of [Cr2(O2CCH3)4(H2O)2].43

Over the years many carboxylate complexes have been reported with metal-tometal distances ranging from ~2.3 to ~2.6 Å.44 Theoretical studies have determined that
both the bridging and axial ligands affect the Cr-Cr bond length.49 The effects of axial
and bridging ligands have been experimentally explored. Elongation of the Cr-Cr
distance of [Cr2(O2CR)4L2] complexes can be achieved substituting with donor ligands
(L) in the axial coordination sites.44,50,51 Changing the bridging ligand in dinuclear
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complexes with no axial ligands demonstrated that the change of N,N and N,O type
ligands with carboxylates have little effect on the Cr-Cr bond length, contrary to
theoretical expectations.52

Scheme 6. Structure of [Cr2(κ1:κ1-μ-pztBu2 )2(κ2-pztBu2 )2].53

More recently, structural analysis of a dinuclear complex of formula [CrII2(κ1:κ1μ-pztBu2 )2(κ2 -pztBu2 )2] (Scheme 6), with Cr···Cr distance 2.7156(7) Å, has given insight
of metal-to-metal bonding at the high limit of the known Cr···Cr distance range and is
recognized as a weak Cr-Cr bond.53 Dimeric pyrazolate complex does not adopt a
paddlewheel structure commonly observed for Cr4L4 acetate complexes. A similar
reported structure [CrII2(tBuNC(CH3)NEt)4] (Scheme 7) shows a significantly shorter CrCr bond of 1.960(1) Å compared to the dimeric pyrazolate complex. Here the limiting
factor is the strain imposed on the Cr-N-N angles by the short Cr-Cr bonds in the
pyrazolate complex. While the amidinate bridges allow the Cr- atoms to approach its
other, the sp2 donor orbital of the pyrazole ligands, favoring a Cr-N-N angle of ~120º, are
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distorted by short Cr-Cr bonds.46 Inconsistent Cr···Cr distances between dinuclear
carboxylate, amidinate and pyrazolate complexes contradicts the structural analogy,
between carboxylates and pyrazolates, that had been determined previously.30,31,33

Scheme 7. Structure of [Cr2(tBuNC(CH3)NEt)4].46

1.6.

Hypothesis and rationale
There are clear structural analogies between carboxylate and pyrazolate

complexes of iron, palladium, platinum, copper, and cobalt. In the case of chromium,
such structural parallel has not been observed between analogous dinuclear carboxylate
and pyrazolate complexes. However, it holds true for higher nuclearity complexes with
more than two metal centers. The existence of analogous dimeric structures of chromium
carboxylate and pyrazolate, compel the current research to synthesize polynuclear
chromium(III) pyrazolate complexes, which will make their redox modification
accessible because of the inertness of pyrazolate ligands compared to carboxylates.
The complexity of magnetism and spectroscopy of trinuclear and octanuclear iron
pyrazolate complexes, observed in experimental magnetic susceptibility data, EPR, and
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NMR spectra, arises from their (2S +1)N microstates, where S is the spin of each metal
center and N is the number of metal centers. High-spin FeIII3 complexes (S = 5/2) have 63
= 216 microstates and high-spin FeIII8, 68 ≈ 1.7x106 microstates. Complexes containing
chromium(III) (S = 3/2) of these structural types (M3 and M8) would simplify the
problem of magnetic exchange in these motifs, yielding species with 43 = 64 and 48 =
65,536 microstates, respectively.
Upon chemical reduction of trinuclear and octanuclear pyrazolate complexes,
mixed-valent species are accessed. Mixed-valent complexes are characterized as
localized or delocalized systems.54 When electron delocalization among the heterovalent
metal centers is permitted, the magnetic exchange becomes further complicated by the
double exchange phenomenon.55–57 Similar questions arise for other M3 or M8 complexes
with the same structural motif.
The current research focuses on the synthesis of polynuclear electrochemically
active chromium pyrazolate complexes. The study of chromium pyrazole/pyrazolate
chemistry has not been developed, elsewhere. The following strategies have been applied
towards that overall goal:

1) Synthesis, characterization, and study of mononuclear chromium pyrazole adducts to
be further used as starting materials for the preparation of polynuclear species.
Pyrazole, as a versatile ligand, can be deprotonated to form bridging bidentate
anions. Synthetic strategies starting from mononuclear pyrazole adducts are a viable
approach in the preparation of polynuclear homo- and hetero-metallic complexes.
Mononuclear iron(III) pyrazole complexes have been isolated and characterized as
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intermediate species in the one-pot synthesis of tri- and octa-nuclear iron pyrazolate
complexes (Scheme 8).58 The synthesis of mononuclear chromium(III) complexes is a
practical approach for the main goal of obtaining polynuclear CrIII pyrazolate complexes.

Scheme 8. Mononuclear ferrous and ferric pyrazole adducts as intermediate in the
polynuclear FeIII pyrazolate synthesis.58
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2) Synthesis of chromium pyrazolate complexes using thermally assisted methods,
analogous to the experimental method used to synthesize chromium carboxylate
complexes.
Most transition metal coordination reactions, to afford large polymetalic clusters
of transition metals, are performed at standard conditions (temperature and pressure).
When using inert ions, such as Cr3+, alternative methods have been pursued.59
Solvothermal syntheses have become widely used for metal complexes of Cr, Fe, Mn and
Ni.60–63 Temperature, pressure, and more recently microwave heating are experimental
synthesis conditions explored by many inorganic chemists. Microwave assisted synthesis
has improved the reaction time and yield of many synthetic procedures. Additionally, it
has lead to novel product formation from the alternative kinetic pathways accessed by the
addition of microwave energy. The use of thermally and microwave assisted syntheses
will be explored in this research.
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Chapter 2: Chromium pyrazole/pyrazolate complexes

2.

Synthesis of mononuclear chromium pyrazole complexes

2.1.

Introduction
There is vast literature on synthetic approaches to obtain polynuclear complexes,

one of which is the oligomerization of simple mononuclear starting materials. Several
transition metals have been reported to form polynuclear pyrazolate complexes; however,
the chromium members of the group have not been fully explored.21
The use of mononuclear chromium(III) complexes with pyrazole can serve as an
efficient strategy to obtain higher nuclearity complexes upon deprotonation by a base, as
has been demonstrated with mononuclear iron pyrazole complexes.58 Despite
considerable study on mononuclear imidazole and pyrazole chromium(II) complexes,
chromium(III) ion has been overlooked.64 Currently, few chromium (III) complexes with
imidazole derivatives have been reported and characterized by infrared, Raman, and EPR
spectroscopy.65 Here we present the first series of chromium(III) pyrazole complexes and
additional products from their synthesis.
2.2.

Results and discussion

2.2.1. Synthesis of CrIII monomers
The complex [mer-CrIIICl3(pzH)3] (1) was obtained by reacting CrCl3·6H2O and
pzH

in THF, while [trans-CrIIICl2(pzH)4]Cl (7) was obtained from the reaction of

anhydrous CrCl2 with pzH in methanol. Scapacci has reported the analogous CrII
complex as [trans-CrII(pzH)4X2] (X = Cl, Br and I).64
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The reaction of CrCl2 and 3-Me-pzH in methanol results in mononuclear
complexes of two structural types: [mer-CrIIICl3(3-Me-pzH)3] (2) and [trans-CrIIICl2(3Me-pzH)4]Cl (8).
Using similar conditions as for pzH, complex [mer-CrIIICl3(4-Me-pzH)3] (4) was
obtained from the reaction of CrCl3·6H2O and 4-Me-pzH in THF, while the complex
trans-[CrIIICl2(4-Me-pzH)4]Cl was not isolated. A purple/pink solution, characteristic of
the trans-complex, was obtained from the reaction workup, which will be discussed
further in section 2.2.6. This same observation was obtained for synthesis of mer-CrIII
complexes with 4-Cl-pzH, 4-Br-pzH and 4-I-pzH.

2.2.2. Crystallographic description of CrIII monomers
Crystallographic data collection and refinement parameters for 1-6 and 7-8 are
summarized in Table 14 and Table 15, respectively. Complexes 1 and 8 crystallized in
monoclinic C2/c space group with half molecule per asymmetric unit. Complex 1
crystallized with the Cl-Cr-N(pzH) atoms on a 2-fold rotation axis. Complexes 2 and 3
crystallized in orthorhombic space group, Pna21 and P212121, respectively. Both,
complexes 4 and 6 crystallized in triclinic P-1 space group. Complexes 5 and 8
crystallized in monoclinic C2/c and P21/c space group respectively. Lastly, complex 7
crystallized in triclinic P-1 space group with two half-molecules related by an inversion
center on the metal atom.
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All complexes contain a 6-coordinate pseudooctahedral CrIII center with [merCrCl3(pz*H)3] or [trans-CrCl2(pz*H)4]Cl coordination sphere. The oxidation state of the
metal center was determined from charge balancing the chemical composition from the
crystal structure and using data from elemental analysis. Complexes 7 and 8 have the
pyrazoles trans to each other in an anti configuration.

Figure 11. Ball-and-stick representation of [mer-CrCl3(pzH)3] (1).
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Figure 12. Ball-and-stick representation of [mer-CrCl3(3-Me-pzH)3] (2).

Figure 13. Ball-and-stick representation of [mer-CrCl3(4-Me-pzH)3] (3).
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Figure 14. Ball-and-stick representation of [mer-CrCl3(4-Cl-pzH)3] (4).

Figure 15. Ball-and-stick representation of [mer-CrCl3(4-Br-pzH)3] (5).
24

Figure 16. Ball-and-stick representation of [mer-CrCl3(4-I-pzH)3] (6).

Figure 17. Ball-and-stick representation of [trans-CrCl2(pzH)4]+ (7) cation. Chloride
counter ion is omitted.
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Figure 18. Ball-and-stick representation of [trans-CrCl2(3-Me-pzH)4]+ (8) cation.
Chloride counter ion is omitted.

Bond lengths and angles are within the expected range for CrIII complexes (Table
3, Table 4, Table 5).66,67 For all the mer-CrIII complexes, the Cr–N bonds trans to a
halogen atom are longer than those trans to a pyrazole, similar to the analogous mer[FeCl3(pz*H)3].58 A short H-bond distance is observed between N—H···O in complex 4
with a THF interstitial solvent molecule in the crystal lattice.

Table 3. Selected bond lengths (Å) for 1-6.
Bond
1
Cr-Cl 2.3231(4)a
2.3242(7)b
Cr-N
a
b

2.072(2)a
2.092(2)b

2
2.371(2)a
2.312(2)a
2.329(2)b
2.076(3) a
2.078(3)a
2.092(3)b

Compound
3
4
2.325(2) a 2.3472(9)a
2.321(2) a 2.3051(9)a
2.327(2) b 2.3228(9)b
2.064(4) a 2.078(2)a
2.053(4) a 2.077(2)a
2.070(4) b 2.108(2)b

trans-Cl–Cr–Cl, or trans-N–Cr–N bonds
trans-N–Cr–Cl bonds
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5
2.310(2) a
2.319(2) a
2.330(2) b
2.069(3)a
2.062(3)a
2.091(3)b

6
2.310(1) a
2.314(1)a
2.307(1)b
2.061(4) a
2.063(4)a
2.091(4)b

Table 4. Selected bond angles (°) for 1-6.
Compound
Bond
Angle
N-Cr-N

1

2

3

4

5

6

87.93(4)
175.85(8)

87.3 - 90.5 88.2 - 89.4 90.1 - 90.9
176.8(1)
177.5(2)
178.48(7)

88.9 - 90.1 89.9 - 91.5
178.6(1)
178.2 (2)

89.40(4)
180.0

88.4 - 91.7 89.4 - 91.7 87.7 - 91.1
177.8(1)
178.5(1)
178.57(5)

87.9-91.4
179.1(1)

Cl-Cr-Cl 90.65(1)
178.69(3)

89.9 - 91.4 89.1 - 91.8 91.0 - 93.2
178.66(4) 179.13(6) 175.71(2)

90.5 - 92.1 91.3 - 91.4
177.24(5) 177.30(5)

Cl-Cr-N

87.9 - 91.5
179.0(1)

Table 5. Selected bond lengths (Å) and angles (º) for 7-8.
Bond Lengths
Cr-Cl
Cr-N

Bond Angle
N-Cr-N
Cl-Cr-N
Cl-Cr-Cl

Compound
7
8
2.3102(7)
2.2939(6)
2.3013(7)
2.066(2)
2.066(2)
2.065(2)
2.079(2)
2.068(2)
2.072(2)
180.0
88.2 - 91.8
89.2 - 90.9
180.0

180.0
89.9 - 90.1
89.2 - 90.7
180.0

Intermolecular distance less than the sum of the van der Waals radii for adjacent
atoms are defined as bonding interactions. The sum of average van der Waals radii for
selected atoms is listed in Table 6. Intermolecular hydrogen bonding interactions are
observed for 1-6 that play major role on the crystal packing of the complexes.
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Table 6. Summarized observed van der Waals radii (Å).68
Bond
H—N
H—Cl
H—Br
H—I
Cl—Cl
Cl—Br
Br—Br
I—Cl
I—I

Sum of van der Waals Radii (Å)
2.52
2.81
2.92
3.10
3.50
3.62
3.74
3.79
4.08

Halogen-halogen interactions give rise to close packing in complexes 4-6,
exhibiting a bent, type II†, R-Xa···Xb-R contact interaction (X = halogen atom).69 The
intermolecular distance between the halogen substituent of the pyrazole and a
coordinated chlorine from an adjacent complex are less than the sum of their van der
Waals radii, Cl5···Cl6 distance and C5—Cl5···Cl6 angle in 4 are 3.299(1) Å and
173.8(2)°, respectively.

Figure 19. Illustration of halogen bonding between Cl atoms on complex 4.

†

Contact interactions are classified as: type I (θ1= θ2) and type II θ1 ≈ 180° and θ2 ≈ 90°. [θ1 (R—Xa···Xb);
θ2 (Xa···Xb—R)]
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Halogen bonging in 5 links two adjacent monomers, resulting in the 3D network
manifested in the crystal packing diagram. Halogen bonding distances and angles are
listed in Table 7. Halogen bonding between Cl···Br results in a 1D chain formation
depicted in Figure 20. The Br···Br halogen bonding links two of the 1D chains resulting
in a 3D network (Figure 21).

Table 7. Halogen-bond geometry for 5. (Å , °).
D—X···Y
d(X—Y)/ Å
D—X—Y/ °
a
C2—Br1···Cl2
3.492(3)
140.7(1)
C5—Br2···Br2b
3.658(3)
138.0(1)
Symmetry codes: (a) x,1+y,z; (b) -x,2-y,1-z

Figure 20. Illustration of crystal packing of 5, showing 1D chains linked by halogen
bonding.
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Figure 21. Illustration of crystal packing of 5, showing two 1D chains linked by halogen
bonding.

Distances and angles for halogen bonding in 6 are shown in Table 8. Bifurcated
halogen bonds are noted between Cl1 and I1/I3. Halogen bonding provides a linkage
between adjacent monomer molecules generating a 2D network.

Table 8. Halogen-bond geometry for 6. (Å , °).
D—X···Y
d(X—Y)/ Å
D—X—Y/ °
a,b
C2—I1···Cl1
3.523
145.9(2)
C5—I2···Cl3b,c
3.487
168.5(1)
b,c
C8—I3···Cl1
3.526
167.9(2)
Symmetry codes: (a) 2-x,1-y,1-z ; (b) x, y, x; (c) x,-1+y,z
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Figure 22. Illustration of crystal packing of 6, showing halogen bonding. THF solvent
molecule and hydrogen atoms were omitted for clarity.

2.2.3. Electrochemistry and electronic absorption spectra of CrIII monomers
Chromium monomers with formula [mer-CrCl3L3] (L=pzH, 4-Me-pzH, 3-MepzH, 4-Cl-pzH, 4-I-pzH and, 4-Br-pzH) were studied electrochemically, showing no
reversible redox processes within the -500 mV to 1500 mV redox potential window. The
UV-Vis spectra of the complexes show no significant differences in the absorption peaks
with variation of the pyrazole substituent. For all compounds, a broad charge transfer
band is observed between 200 - 280 nm. Charge transfer bands are spin-allowed and
Laporte-allowed, in contrast to the Laporte-forbidden d-d transitions bands, which causes
marked intensity differences between them. Two d-d transition bands were observed from
380 - 800 nm, listed in Table 9.
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Figure 23. UV-Vis of [mer-CrCl3(pzH)3] (1) (6.4x10-4 M) in MeOH.

Table 9. Wavelength for d-d transitions for complexes 1-6.
Complex λmax1 (nm) / υ2 (cm-1)
448 / 22321
1
446 / 22421
2
439 / 22779
3
464 / 21552
4
451 / 22173
5
452 / 22173
6
410 / 24390
7
409 / 24450
8

λmax2 (nm) / υ1, 10 Dq (cm-1)
614 / 16287
608 / 16447
599 / 16695
638 / 15674
626 / 15974
618 / 16181
546 / 18315
555 / 18018

Crystal field theory predicts that the Russell-Saunders ground state for free ion
CrIII, 4F, splits into: 4T1g, 4T2g, and 4A2g substates for octahedral environment.70 Ligand
coordination lowers the symmetry of the metal center, causing loss of degeneracy as
depicted in Scheme 9. Two spin-allowed bands corresponding to 4A2g - 4T2g(F) (υ1) and
4

A2g - 4T1g(F) (υ2) transitions are observed. The lowest energy transition (υ1) corresponds

to 10Dq, the ligand field splitting energy.71
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Scheme 9. Splitting of the ground state term 5F (d3 free ion) (arrows show spin allowed
transitions in an octahedral (Oh) environment).
Additional pyrazole ligand in 7 causes shifting to higher energy, compared to 1,
which is consistent with the stronger ligand field of an additional nitrogen atom. Similar
energy shifts have been observed for CrIIL2Cl2 and CrIIL4Cl2 (L= pyrazole,
dimethylpyrazole and imidazole).64 Solvent effect on charge transfer bands have been
experimentally and theoretically studied.72,73 Absorption spectra in various solvents were
recorded for complex 1, where an inverse linear dependence of charge transfer (CT)
energy and solvent dielectric constant is obtained, same as other chromium(III)
complexes (Figure 24).72
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Figure 24. Dielectric constant (Fm-1) of solvent as a function of charge transfer (CT) band
energy (cm-1) for complex 1.

2.2.4. Nuclear magnetic resonance and electron paramagnetic resonance
Paramagnetic complexes have small electron spin relaxation times that causes a
resonance broadening-flattening in the NMR and sometimes the spectrum disappears.74
The effect of the paramagnetic environment to the spin relaxation is timescale dependent,
which is reduced when the lifetime of the electron spin relaxation is short, allowing to
record a NMR spectrum.54 Electron paramagnetic resonance (EPR) is a technique that
probes transitions between electron-spin quantum states (mS), rather than nuclear-spin
quantum states (mI) observed by NMR.75 Electron paramagnetic resonance is used to
study the spin-state in paramagnetic complexes.76 The technique is used to characterize
spin-state, to confirm the spin-state determined by magnetic susceptibility, or to
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determine the localization or delocalization of spin in a metal complex. For some
compounds with intermediate electron-spin relaxation rate, both the NMR and the EPR
are possible to record, because the relaxation is slow enough for an EPR and fast enough
for NMR spectrum to be recorded.77

Nuclear magnetic resonance of CrIII monomers

2.2.4.1.

Chromium(III), d3 ions have an electronic spin of S = 3/2 and typically a very
small zero-field splitting parameter (D); the electronic configuration determines their
relaxation properties. The most efficient relaxation mechanism for high-spin Cr3+
complexes is often the modulation of transient zero-field splitting (ZFS).78 The ZFS has
strong influence on the resonance of nuclear spins in solution, this effect has been
theoretically studied for transition metal complexes.79,80
Some mononuclear chromium(III) complexes with pincer-type ligands containing
a central pyridine moiety have no detectable signals in the in the range from −300 to
+300 ppm, due to their fast relaxation rate.81 In the case of complex [mer-CrCl3(pzH)3]
(1), NMR signals were observed. Spectra of 1 should contain two distinct pyrazole
environments, one resonance for the protons of the pyrazoles trans to each other and the
other for the pyrazole in the cis position. Unbound pyrazole (pzH) shows singlet
resonance 12.82 ppm for H1-N, doublet at 7.59 ppm for H3/5, and a triplet at 6.25 ppm for
H4. Unlike free pyrazole, H3 and H5 on the mer-CrIII complex are not equivalent due to
the metal coordination; a total of eight resonances should appear on the NMR for
complex 1.
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Contrary to the expected, 1 showed fewer resonances in acetone-d6 and
acetonitrile-d3. Spectra of 1 showed peaks at 7.60 ppm and 6.30 ppm with integration
1:0.5, respectively. Line broadening and signal/noise ratio of the observed peak at -9.00
ppm causes integration problems. The broad peak of 1 at -9.00 ppm is absent in the
spectrum 3, suggesting assignment to the H4 proton (Figure 25). In complex 3, a new
resonance at 2.97 ppm, corresponds to the 4-Me group. The NMR spectra of complexes
4, 5 and 6 are depicted on Figure 26. Complex 4 and 5 have two resonances, whereas 6
showed one distinct peak.‡

Figure 25. 1H NMR of complex 1 (red) and 3 (green) in Acetonitrile-d3 at 400 MHz.
Spectra was referenced to the residual solvent proton resonance.

‡

Complex [mer-CrCl3(3-Me-pzH)3] (2) had poor solubility in acetone and acetonitrile, peak
assignment was not successful.
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Figure 26. 1H NMR of complex 1 (purple), 3 (blue), 4 (green), 5 (orange) and 6 (red) in
Acetonitrile-d3 (red) at 400 MHz.

Paramagnetic upfield shift and line broadening in observed for complex 1. A
similar case has been reported for the mononuclear chromium(III) tris-(8hydroxyquinolinate) complex that shows signals with large paramagnetic shifts to high
frequencies and spectral broadening.82 Chemical shifts are determined by the nature of
metal-ligand interaction.83 Shifts might come from either through-space dipolar
interaction (pseudo-contact) or direct delocalization of electron density from the metal
(contact shift).84 Contact and pseudo contact interactions cause a paramagnetic chemical
shift effect on complex 1.
To further comprehend the NMR spectra of mononuclear chromium complexes,
variable temperature NMR was recorded. Variable temperature NMR of paramagnetic
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complexes should show temperature dependence on chemical shift, while the line width
should remain constant.85 Variable temperature NMR spectra of complex 1 were recorded
in acetone-d6 solution over the -60 °C to +23 °C range (Figure 28). All resonances
showed temperature dependent downfield shift upon cooling except for broad peak at 9.00 ppm (F), which was shifted upfield upon cooling. The intensity of peak at 7.60 ppm
(AB) decreases and two new peaks at 7.40 (A) and 7.80 ppm (B) appeared. While the
intensity of peak at 6.30 ppm (D) decreases, the intensity of the 6.20 ppm peak (C)
increases upon cooling. The set of peaks around 7.30 ppm (A and B) showed coalescence
at room temperature. However, peaks at 6.20 ppm (C) and 6.30 ppm (D) remain at room
temperature. Signals E and F are attributed to H4 of the pyrazole, peak assignments
remains unclear because of line broadening, signals are absent for 4. Curie temperature
dependence is observed for proton signals for complex 1. Curie temperature dependence
can be determined from the linear plot of chemical shift as a function of inverse
temperature in K that should have positive slope for downfield shift and negative slope
for upfield shift upon cooling (Figure 29).86,87

Figure 27. 1H NMR peak assignment for 1.
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Figure 28. Variable temperature 400 MHz 1H NMR of complex 1 in acetone-d6.
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Figure 29. Temperature dependence of H chemical shifts of complex 1.
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Variable temperature spectra of complex 4 were recorded in acetone-d6 solution
over the -50 °C to +23 °C range (Figure 31), showing similar behavior compared to 1.
Disappearance of peaks E and F (of 1) is consistent with their assignment to the H4 of the
pyrazole. Resonances showed temperature dependence, increasing the downfield
chemical shift and Δν (difference in chemical shift) upon cooling. The intensity of peak at
7.71 ppm (AB) decreases while intensities of peaks at 7.45 (A) and 7.94 ppm (B)
increases. Intensity of peak at 5.61 ppm (D) decreases and intensity of peak at 5.94 ppm
(C) increases. The set of peaks around 7.3 ppm (A and B) did not show coalescence at
room temperature. Coalescence temperature (Tc) of peaks A and B is approximately 30
°C. In contrast, the set of peaks at around 6 ppm (C and D) showed Tc at room
temperature (23 °C).

Figure 30. 1H NMR peak assignment for 4.
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Figure 31. Variable temperature (-50 to +23 °C) 400 MHz 1H NMR of complex 4 in
acetone-d6.
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Figure 32. Temperature dependence of H chemical shifts of complex 4.
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Raising the temperature, for complexes 1 and 4, caused proton shifts to become
coalesced into a single line. At low temperatures the rate of pyrazole tautomerization is
low†, causing separate signals for protons at position H3 and H5 of the pyrazole to be
observed separetely.88 The presence of four resonances, instead of eight resonances, in
the spectra is consistent of corresponding pyrazole sites: pyrazole trans to a pyrazole and
pyrazole trans to a chloride. At room temperature, for both 1 and 4, peaks around 7.5
ppm and peaks around 6 ppm have 1:2 integration, consistent with the previous
assignment. Similar temperature behaviors should be expected for complexes 3, 5 - 6.

2.2.4.2.

Electronic paramagnetic resonance of CrIII monomers
The X-band electron paramagnetic resonance (EPR) of chromium(III) monomers

with formula [mer-CrCl3(4-H-pzH)3] (1) and [mer-CrCl3(4-Cl-pzH)3] (4) were run by
collaboration with Joshua Telser (Roosevelt University, Chicago) (Figure 33). The Xband EPR shows broad hyperfine lines typical for a high-spin center from a ground state
S = 3/2 with a small zero-field splitting (ZFS). Simulation of the experimental data will
help elucidate EPR parameters like the axial zero-field splitting (D) and the gyromagnetic
ratio (g), a distribution in the parameters is expected due to slight structural differences
between complexes.89

†

Energy barrier is calculated from
, where T is temperature (in
-1
K), k is the rate constant (in s ). Rate constant is defined by
, where υAB is the chemical shift
(in Hz) between peaks X and Y. ( 1; ΔG≠AB =13.9 kcal/mol, ΔG≠CD =14.5 kcal/mol; 4, ΔG≠AB =14.0
kcal/mol, ΔG≠CD =13.4 kcal/mol)
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Figure 33. X-Band EPR of 1 (red) and 4 (green) (9.376 GHz), 10 K.
The Q-band EPR spectra of acetonitrile (MeCN) solutions of 1, 3, and 4 were
recorded in collaboration with Dr. Athanassios K. Boudalis (University of Strasbourg,
France). The spectra revealed a derivative main feature around 1220 mT (g ~ 1.99)
accompanied by broader and weaker satellite features. These features were attributed to
weak zero-field splittings of the single ions, but their broad features could not be
reproduced by such a simple model. It was then considered that the system undergoes
strain effects, which induce distributions of the effective spin Hamiltonian parameters (gand/or D-strains). Due to the relevance of ZFS in the appearance of the satellite features,
only a D-strain model was assumed to account for parameter distributions, considering
the g-tensor components as monodisperse. The D parameter was considered as following
a normal distribution.
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Figure 34. Q-band EPR experimental (black lines) and calculated (red lines) spectra of
frozen MeCN solutions. The insets show the distribution of the D parameter.

Table 10. Best-fit parameters for the Q-band EPR spectra of complexes.
Compound
g||
1.99
1
1.99
3
1.99
4
[Note: σ is the intrinsic linewidth].

σ (Gpp)
18.1
15.8
27.9

g
1.99
1.99
1.99

44

|D| (cm-1)
0.16
0.15
0.073

σD (cm-1)
0.18
0.17
0.25

For this case, the expression for the g factor is defined by:
(1)
where Δ is 10Dq (from Table 9), the energy difference from 4A2g and 4T2g levels.90 Spinorbit coupling constants (λ) are calculated for compound 1, 3, and 4 taking into account
that for the Cr+3 free ion λ0 = +91 cm-1. The π-acceptor character of the pyrazole ligands
is reflected on the reduction of the spin-orbit constants, where the spin orbit reduction
factor (k) is defined by λ = k2λ0. Similar effect had been observed for complexes with
imidazole and pyridine ligands.65,91

Table 11. Spin-orbit coupling constants (cm-1) for 1, 3, ad 4.
Compound
1
3
4

Δ (cm-1)
16287
16695
15674

λ (cm-1)
25.1
25.7
24.1

λ/ λ0
0.276
0.283
0.265

k
0.525
0.532
0.515

The ZFS parameter |D| for mononuclear chromium(III) complexes with
monodentate ligands typically falls in the range of 0.06 - 0.1 cm-1 and the corresponding
g values at approximately 1.98 - 1.99, which is comparable with the obtained |D| and g
values for 4.92,93 Increase in |D| values can be attributed to a larger spin-orbit constant
from the ligand in 1 and 3.
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2.2.5. Base addition to mononuclear CrIII pyrazole complexes
Higher nuclearity complexes are expected to form from the deprotonation of
coordinated pyrazole ligands. Mononuclear complexes with formula [mer-CrCl3(pz*H)3]
were reacted with a variety of bases in organic and inorganic solvents to deprotonate the
coordinated pyrazoles and possibly accomplish higher nuclearity complexes. Change in
color is observed from green to pink in the reaction of [mer-CrCl3(pzH)3] (1) with
triethylamine in acetonitrile. A time-dependant UV-Vis experiment shows two isosbestic
points at 427 nm and 496 nm. A third “isosbestic point” at 583 nm is blurred, implying
the presence of a minor impurity that absorbs close to that wavelength.94 Failure to isolate
pure product has hampered all attempts of base addition reactions in various solvents and
isolation methods.

Figure 35. Time-dependant UV-Vis spectra for the reaction of [mer-CrCl3(pzH)3] (1) with
triethylamine in acetonitrile.
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2.2.6. Other products from mononuclear CrIII pyrazole syntheses
Further study of mononuclear chromium complexes syntheses has provided
insight on the difficulty of product isolation from base addition reactions. From the
reaction mixture of CrCl3·6H2O and 3-Me-pzH in dichloromethane (DCM), where green
crystals of [mer-CrCl3(3-Me-pzH)3] (2) and [trans-CrCl3(3-Me-pzH)3]Cl (8) were
isolated, trace amount of [CrIII3(μ3-O)(μ-OH)3(3-Me-pzH)9]Cl4 (9) was also obtained as
pink crystals. Bulk synthesis of (9) was not successful from the stoichiometrically
optimized reaction. Isolation of analogous material using similar reaction conditions with
other pyrazole ligands was then attempted.

Figure 36. Ball and stick representation of [CrIII3(μ3-O)(μ-OH)3(3-Me-pzH)9]Cl4 (9).
Some hydrogen atoms are omitted for clarity.
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The use of 4-Me-pyrazole ligand was explored using similar reaction conditions,
as complex (9), from which the analogous trinuclear complex with [Cr3(μ3-O)(μ-OH)3]
core was not isolated. Instead, green crystals of [mer-Cr3Cl3(4-Me-pzH)3] (3) were
obtained. Additionally, purple crystals of dinuclear complex with formula [CrIII2(μOH)(μ-4-Me-pz)(4-Me-pzH)4Cl4] (10) and pink crystals of [CrIII2(μ-OH)(μ-4-Me-pz)2(4Me-pzH)4Cl2]Cl (11) were obtained in a very low yield.

Figure 37. Ball and stick representation of [CrIII2(μ-OH)(μ-4-Me-pz)(4-Me-pzH)4Cl4]
(10) Dashed red lines represent H-bonds.
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Figure 38. Ball and stick representation of [CrIII2(μ-OH)(μ-4-Me-pz)2(4-Me-pzH)4Cl2]Cl
(11). Dashed red lines represent H-bonds.

To address the problem of low yields for the aforementioned dinuclear complexes
syntheses, anhydrous CrCl2 and 4-R-pyrazole (R = Me, H, Cl) were reacted in DCM.
Reactions yielded mononuclear complex of form [mer-Cr3Cl3(4-R-pzH)3] as the major
product and traces of dinuclear complex with general formula [CrIII2(μ-OH)(μ-4-Rpz)2(4-R-pzH)4Cl2]Cl, R= Me (11), H (12) and Cl (13).
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Figure 39. Ball and stick representation of [CrIII2(μ-OH)(μ-pz)2(pzH)4Cl2]Cl (12). Dashed
red lines represent H-bonds.

Figure 40. Ball and stick representation of [CrIII2(μ-OH)(μ-4-Cl-pz)2(4-Cl-pzH)4Cl2]Cl
(13). Dashed red lines represent H-bonds.
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The described trinuclear and dinuclear pyrazolate complexes can be synthesized

from the same reaction mixture from which the mononuclear complexes with mer- and
trans- configuration were obtained. Metal coordination shows an increase in pyrazole
acidity, since no base addition yielded dinuclear pyrazolate complexes. In all cases,
efforts to improve the yield of dinuclear and trinuclear species were unsuccessful, due to
the formation of stable mer- complexes. Equilibrium between mononuclear, dinuclear,
and trinuclear complexes in solution is the source of complexity in isolating polynuclear
products after the addition of base to complexes of mer- configuration.
Analogous

dinuclear

chromium

acetate

complexes

with

[Cr2(μ-OH)(μ-

O2CR)2(L)6]3+ motif have been shown to be intermediates of formation of oxo-centered
trinuclear complexes with form [Cr3(μ3-O)(μ-O2CR)6(L)3]+.95–97 Following that most
trinuclear chromium acetate complexes are achieved by thermal treatment routes; the
trinuclear motif with formula [CrIII3(μ3-O)(μ-pz*)6L3] should be achievable with the use
of high temperatures following the addition of base. To prevent the formation of mercomplexes, chromium source without chloride was considered.
2.2.6.1.

Crystallographic description of trinuclear and dinuclear complexes
Crystallographic data collection and refinement parameters for 9-13 are

summarized in Table 16. Complex 9 crystallized in cubic Pa-3 space group with one
third of the molecule per asymmetric unit and 4/3 Cl- counter ions. Complex 10
crystallized in trigonal P-3c1 space group with one half molecule per asymmetric unit.
Complexes 11, 12, and 13 are isostructural and crystallized in the P21/c space group with
a whole molecule per asymmetric unit.
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Complex 9 has three 6-coordinate octahedral CrIII centers contained on a plane
with Cr···Cr distance 2.952(2) Å and also coordinated to three 4-Me-pzH ligands.
Bridging μ3-O and one Cl- counter ion are located on a 3-fold rotation axis, Cr-Oμ bond
length 1.965(4) Å. Adjacent chromium centers are bridged by μ-OH, with Cr-Oμ bond
length of 1.945(4) Å. Complex 9 crystallized with four chloride counter ions showing
hydrogen bonding with pyrazole ligands.
Complex 10 contains two 6-coordinate octahedral CrIII centers bridged by a μ-OH
and a μ-4-Me-pz. Each chromium center is also coordinated to two 4-Me-pzH ligands
and two chloride atoms. In contrast, complexes 11, 12, and 13 contain two bridging
pyrazolate ligands and one terminally coordinated chloride per Cr center. Complex 10 is
neutral, while 11, 12, and 13 co-crystallized with a chloride counter anion. Selected bond
distances are listed in Table 12. There is a considerable metal-to-metal distance reduction
upon the increase number of bridging pyrazolate ligand. No obvious difference in Cr···Cr
distance is observed within dinuclear complexes with 4-Me-pzH and 4-H-pzH, in contrast
to the elongated Cr···Cr distance of the 4-Cl-pzH complex. Analogous dinuclear
complexes are known with carboxylate ligands, bond lengths and angles are summarized
in Table 13. Pyrazolate complexes have a reduced Cr···Cr distances and Cr—OH—Cr
angles, associated with their higher rigidity and reduced bite angle of the pyrazolate
compared to the carboxylate ligand. However, the Cr···Cr distances of 11, 12 and 13 are
still too long for metal-metal bonding.
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Table 12. Selected bond lengths (Å) and angles (°) for dinuclear chromium pyrazolate
complexes.
Compound
Bond
Cr···Cr
Cr—Cl

10
3.4685(4)
2.2993(2)

Cr—N(μ)
Cr—N

2.0123(1)
2.0759(2)
2.0573(2)
1.9554(2)

Cr—O

Cr—OH—Cr 124.977(5)

11
3.2482(2)
2.3216(1)
2.3079(2)
2.0208(1)-2.0261(1)
2.0671(2)-2.0869(1)

12
13
3.2402(2)
3.2649(5)
2.3113(1)
2.3026(4)
2.3159(1)
2.3250(3)
2.0190(1)-2.0831(1) 2.0250(3)- 2.386(2)
2.0735(1)-2.0881(2) 2.0754(3)-2.1053(2)

1.9406(1)-1.9495(1)
113.228(4)

1.9462(1)
1.9417(1)
112.902(2)

1.9472(2)
1.9532(3)
113.66(1)

Table 13. Bond lengths (Å) and angles (°) for selected CrIII carboxylate complexes
Complex
[Cr2(tren)2(μ-OH)(μ-O3C)](ClO4)398
[Cr2(OH2)8(μ-OH)(μ-O2CCH3)]((CH3)3C6H2SO3)497
[Cr2(OH2)6(μ-OH)(μ-O2CH)2](p-CH3)3C6H2SO3)496

2.3.

Bond length (Å)
Cr···Cr Cr—μO
1.944(2)
3.560
1.92(1)
3.55(1)
3.381(1) 1.920(4)

Angle (°)
Cr—OH—Cr
131.5(3)
133.1(7)
123.4(2)

Conclusions
Complexes with formula [mer-CrCl3(pz*H)3] (pzH = pyrazole ligand; pz*H = 3-

Me-pzH, 4-Me-pzH, 4-Cl-pzH, 4-Br-pzH, 4-I-pzH) and [trans-CrCl2(pz*H)4]Cl (pz*H =
pzH, 3-Me-pzH) were synthesized and characterized. Complexes are both NMR and EPR
active. Variable temperature NMR elucidated that fewer number of resonance peaks is
caused by tautomerism in solution. The EPR data show broad hyperfine lines typical for a
high-spin chromium center. The ZFS parameter |D| for mononuclear chromium(III)
complexes 1, 3 and 4 was determined and falls within range compared to other
chromium(III) complexes with monodentate ligands Increase in |D| values are attributed
to a larger spin-orbit constant from the ligand in 1 and 3. Polynuclear complexes were not
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isolated from base addition to mononuclear chromium complexes. Trinuclear complex
with formula [CrIII3(μ3-O)(μ-OH)3(3-Me-pzH)9]Cl4, dinuclear complexes with formula
[CrIII2(μ-OH)(μ-4-Me-pz)(4-Me-pz)4Cl4] and [CrIII2(μ-OH)(μ-4-R-pz)2(4-R-pz)4Cl2]Cl (R
= Me, H and, Cl) were isolated as side products of mononuclear complex syntheses.
Equilibrium of mentioned complexes in solution with the mononuclear complexes might
have prevented the isolation of pure polynuclear complexes from their reaction with base.
The use of chromium sources without chloride and thermally assisted synthesis may
improve the yields of the aforementioned trinuclear and dinuclear complexes. Analysis of
magnetic data from complexes with formula [CrIII3(μ3-O)(μ-OH)3(pzH)9]+4 could
elucidate the existence of a metal-to-metal bond. As previously mentioned, Cr-Cr bonds
range between 1.74 - 2.69 Å, which make this complex the top limit of its kind, given
that the observed Cr···Cr distance was 2.952(2) Å.
2.4.

Experimental section

2.4.1. Materials
Reagent grade chemicals were purchased from Fisher scientific, Aldrich Chemical
Co, Alfa Aesar or ACROS Organics. Reactions were performed at room temperature.
Elemental analyses of crystalline material were performed by Galbraith Laboratories,
Knoxville, TN.
2.4.2. Instrumentation
Electrochemical experiments were performed with a BAS CV 50 W voltammetric
analyzer in 0.1 M Bu4NPF6/CH2Cl2 using a non-aqueous Ag/AgNO3 reference electrode
for which the ferricenium/ferrocene couple occurs at 0.200 V, glassy carbon auxiliary
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electrode, and glassy carbon working electrode. 1H NMR spectra were recorded on a 400
Bruker NMR spectrometer and were referenced, using the residual solvent resonances.
FT-IR and UV-Vis spectra were recorded at room temperature with a Perkin Elmer
Spectrum 100 FT-IR S and a Varian Cary 3000 spectrometer, respectively.
2.4.3. Synthesis and characterization
2.4.3.1.

Synthesis of [mer-CrCl3(pzH)3] (1).

Method A: A 25 mL flask was charged with 124.4 mg (0.466 mmol) of CrCl3·6H2O and
dissolved with 15 mL of THF followed by addition of 159.9 mg (2.35 mmol)
of pyrazole (pzH). The solution was left stirring for 24 hours. Dark green
crystals of (1) were obtained from slow evaporation of solvent; crystal yield,
107 mg (66 %). Elemental analysis calculated for C9H12Cl3CrN6: C, 29.81;
H, 3.34; N, 23.18. Found: C, 29.46; H, 3.35; N, 22.98. FTIR (cm-1,solid): 669
m, 712 s, 765 s, 868 w, 908 w, 944 w, 1046 s, 1118 s, 1160 w, 1261 w, 1345
m, 1401 w, 1470 m, 1514 w, 3143 w, 3307 m, 3354 w. UV-Vis (MeOH) λmax
(ε); nm (M-1 cm-1): 448 (62.0), 614 (37.0). 1H NMR (400 MHz, CD3CN) δ
7.70 (1), 6.30 (0.5), -9.00 (11).
Method B: 153 mg (1.25 mmol) of CrCl2 were suspended in 10 mL of DCM, followed by
the addition of 345.5 mg (5.07 mmol) of pyrazole. Green crystals of (1) are
isolated from diethyl ether vapor diffusion into a DCM solution. Pink crystals
of [CrIII2(μ-OH)(μ-pz)2(pzH)4Cl2]Cl (12) were isolated from evaporation of
diethyl ether/DCM solution.
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2.4.3.2.

Synthesis of [mer-CrCl3(3-Me-pzH)3] (2).

Method A: A 25 mL flask was charged with 106.0 mg (0.86 mmol) of CrCl2 and
dissolved with 10 mL of methanol at room temperature. Translucent green
solution was obtained to which 220.0 μL (2.60 mmol) of 3-Methyl-pyrazole
(3-Me-pzH) were added drop-wise and left stirring for 24 hours. Product was
isolated from reduced pressure vaporization of solvent. Dark green single
crystals of (2) were obtained from hexane solvent layering in a DCM
solution. Elemental analysis calculated for C12H18Cl3CrN6: C, 35.62; H, 4.48;
N, 20.77. Found: C, 35.31; H, 4.88; N, 20.08. FTIR (cm-1, solid): 675 vs, 791
vs, 808 s, 956 s, 1016 w, 1105 vs, 1283 w, 1411 w, 1444 w, 1487 w, 1559 m,
3135 vw, 3312 m. UV-Vis (MeOH) λmax (ε); nm (M-1 cm-1): 446 (41.4), 608
(38.6).
After removal of green crystals from the reaction mixture of (2), trace mount
of pink single crystals of [trans-CrCl2(3-Me-pzH)4]Cl (8) were obtained from
evaporation of a 1:1 dichloromethane/hexane mixture.
Method B: A 25 mL flask was charged with 299.7 mg (1.12 mmol) of CrCl3·6H2O,
followed by addition of 10 mL of DCM. To the resulting suspension, 360
μL (4.42 mmol) of 3-Me-pzH was added. Green crystals of (2) were
obtained from slow evaporation of solvent after filtration. Trace amounts of
[CrIII3(μ3-O)(μ-OH)3(3-Me-pzH)9]Cl4 (9), were also collected as blue
crystals.
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2.4.3.3.

Synthesis of [mer-CrCl3(4-Me-pzH)3] (3).

Method A: A translucent green solution was obtained from dissolving 118.7 mg (0.445
mmol) of CrCl3·6H2O in 15 mL of THF. A 2 mL solution of 189 μg (2.233
mmol) of 4-Methyl-pyrazole (4-Me-pzH) in THF was then added drop wise.
Green single crystals of (3) were obtained from slow evaporation of solvent;
crystal yield 54 mg (30 %). Elemental analysis calculated for C12H18Cl3CrN6:
C, 35.62; H, 4.48; N, 20.77. Found: C, 35.68; H, 4.43; N, 20.53. FTIR (cm-1,
solid): 658 w, 693 m, 744 w, 966 m, 1001 s, 1071 s, 1118 s, 1237 w, 1292 w,
1334 w, 1390 w, 1477 m, 1692 w, 2931 w, 3120 w, 3280 s, 3305 w. UV-Vis
(MeOH) λmax (ε); nm (M-1 cm-1): 439 (55.0), 599 (43.0). 1H NMR (400 MHz,
CD3CN) δ 7.41 (0.5), 5.44 (1), 2.97 (17).
Method B: A round bottom flask was charged with 109.7 mg (0.411 mmol) of
CrCl3·6H2O followed by 5 mL of DCM. To the suspension, 104.8 μL (1.287
mmol) of 4-Me-pzH was added, followed by reflux for 4 hours. After
evaporation of solvent, green crystals of (3) were obtained from DCM/ ether
vapor diffusion. Green crystals and pink solution were observed from the
crystallization set up. Traces of purple crystals of [CrIII2(μ-OH)(μ-4-Mepz)(4-Me-pzH)4Cl4] (10) and pink crystals of [CrIII2(μ-OH)(μ-4-Me-pz)2(4Me-pzH)4Cl2]Cl (11) were collected from slow evaporation of pink solution.
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2.4.3.4.

Synthesis if [mer-CrCl3(4-Cl-pzH)3] (4).

Method A: A 25 mL flask was charged with 50.6 mg (0.190 mmol) of CrCl3·6H2O and
dissolved with 15 mL of THF. To the obtained green solution, 99.7 mg (0.97
mmol) of 4-Chloro-pyrazole (4-Cl-pzH) was added and left to stir for 24
hours. Solvent was removed under reduced pressure and dark green single
crystals of (4) were obtained from diethyl ether vapor diffusion in DCM
solution; crystal yield 162 mg (69%). Elemental analysis calculated for
C9H9Cl6CrN6: C, 23.20; H, 1.95; N, 18.04. Found: C, 23.18; H, 2.12; N,
17.15. FTIR (cm-1, solid):679 vs, 847 s, 964 vs, 1050 vs, 1113 vs, 1203 m,
1259 m, 1339 m, 1391 m, 1463 m, 1530 m, 1691 w, 3124 w, 3263 m, 3331
w. UV-Vis (MeOH) λmax (ε); nm (M-1cm-1): 448 (65.0), 618 (30.0). 1H NMR
(400 MHz, CD3CN) δ 7.58 (1), 5.43 (0.4).
Method B: A 25 mL flask was charged with 122 mg (1.00 mmol) of CrCl2 followed by
10 mL of DCM. To the resulting suspension, 254.8 mg (2.50 mmol) of 4-ClpzH was added. Green crystals and pink solution were obtained after
diffusing diethyl ether to the DCM solution. Slow evaporation of pink
solution yielded trace amounts of pink crystals of [CrIII2(μ-OH)(μ-4-Clpz)2(4-Cl-pzH)4Cl2]Cl (13).
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2.4.3.5.

Synthesis of [mer-CrCl3(4-Br-pzH)3] (5)
A 25 mL flask was charged with 119.8 mg (0.500 mmol) of CrCl3·6H2O and

dissolved with 15 mL of THF. To the obtained green solution, 264.5 mg (1.806 mmol) of
4-Bromo-pyrazole (4-Br-pzH) was added and left to stir for 24 hours. Green single
crystals of (5) were obtained from slow evaporation of solvent; crystal yield 75 mg
(28%). Elemental analysis calculated for C9H9Br3Cl3CrN6·0.3C4H8O: C, 19.73; H, 1.85;
N, 13.54. Found: C, 19.10; H, 1.71; N, 12.68. FTIR (cm-1, solid): 671 s, 877 s, 821 m,
856 s, 877 m, 945 s, 1046 s, 1118 s, 1188 w, 1210 w, 1260 w, 1343 w, 1388 s, 1460 w,
3133 w, 3252 m, 3306 w, 3360 w. UV-Vis (MeOH) λmax (ε); nm (M-1 cm-1): 451 (43.0),
626 (27.0). 1H NMR (400 MHz, CD3CN) δ 7.60 (1), 5.44 (0.5).
2.4.3.6.

Synthesis of [mer-CrCl3(4-I-pzH)3] (6).
A translucent green solution was obtained after dissolving 111.3 mg (0.418

mmol) of CrCl3·6H2O with 15 mL of THF in a 25 mL flask. Then 404.3 mg (2.08 mmol)
of 4-Iodo-pyrazole (4-I-pzH) was added to the stirring solution and left to react for 24
hours. Solvent was removed by reduced pressure. Dark green single crystals of (6) were
obtained from diethyl ether vapor diffusion to a DCM solution; crystal yield 31.6 mg
(10%).

Anal

Elemental

analysis

calculated

for

C9H9Cl3I3CrN6·1.15

C4H8O (C13.6H18.2Cl3CrI3N6O1.15): C, 19.84; H, 2.23; N, 10.21. Found: C, 19.74; H, 2.29;
N, 10.07. FTIR (cm-1, solid): 703 s, 839 m, 858 w, 939 vs, 963 w, 1052 vs, 1118 s, 1190
w, 1247 w, 1330 w, 1379 w, 1458 w, 1510 vw, 1772 vw, 2969 vw, 3132 w, 3233 m. UVVis (MeOH) λmax (ε); nm (M-1 cm-1): 452 (56.95), 618 (31.32). 1H NMR (400 MHz,
CD3CN) δ 7.63.
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2.4.3.7.

Synthesis of [trans-CrCl2(pzH)4]Cl (7).
A 25 mL flask was charged with 489.0 mg (4.00 mmol) of CrCl2 and dissolved in

10 mL of MeOH. To the translucent green solution, 1.0927 g (16.0 mmol) pyrazole (pzH)
was added. Reaction mixture was left to stir and react for 24 hours. After filtration, the
solvent was removed under reduced pressure. Purple/pink single crystals of (7) were
obtained from solvent laver diffusion of hexane to a DCM solution. Anal. Calcd for
[CrCl2pzH4]Cl (C12H16Cl3CrN8) : C, 33.47; H, 3.74; N, 26.02. Found: C, 34.10; H, 3.65;
N, 25.87. FTIR (cm-1, solid): 761 s, 878 w, 909 w, 949 w, 1046 vs, 1115 m, 1255 w, 1277
w, 1349 m, 1379 m, 1405 w, 1605 m, 1525 wm 1626 w, 2934 w, 2977 w, 3133 b. UVVis (MeOH) λmax (ε); nm (M-1 cm-1): 410 (47), 546 (30).
2.4.4. Crystal structure and structure refinement data
Single crystals X-ray diffraction data were measured on a Bruker D8 QUEST
CMOS system equipped with a TRIUMPH curved-crystal monochromator and a Mo Kα
fine-focus tube or a Bruker APEX II area detector with graphite monochromated Mo Kα
radiation (λ = 0.71073 Å). Frames were integrated with the Bruker SAINT software
package using a narrow-frame algorithm. Absorption effects were corrected using the
multi-scan method (SADABS). Using Olex299, structures were solved by intrinsic or
direct methods with ShelXT100 and refined with ShelXL101 using full-matrix least-squares
minimization. All non-hydrogen atoms were refined anisotropically. Hydrogen atoms
positions were calculated using the riding model. Complex 4 showed a positional
disorder in one Cl atom and complex 6 showed a crystallographic positional disorder in
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all I atoms, resolved with the PART instruction. Disordered interstitial THF solvent
molecule in 6 was resolved with SQUEEZE.
2.4.5. EPR measurements
Q-band EPR was recorded on an EMX plus spectrometer fitted with an EMX
premium Q microwave bridge and an ER5106QTW microwave resonator operating in the
TE012 mode and controlled by the Bruker Xenon software. For low-temperetaure
experiments, the resonator was fitted in an Oxford CF935 dynamic continuous flow
cryostat. The spectra were fitted with Easyspin V 5.2 using home-made routines.
Experimental conditions: fEPR = 34.00 GHz, mod. ampl. = 5 Gpp, PEPR = 1.15 mW. R = H:
T = 80 K. R = Me: T = 79 K. R = Cl: T = 82 K.
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Table 14. Structure refinement parameters for complexes 1 - 6.
Compound
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
Crystal size/mm3
Reflections
collected/2Θmax(°)
Data/restraints/
parameters
Goodness-of-fit on F2
R1, wR2 [I>=2σ (I)]
R1, wR2 [all data]

(1)
C9H12Cl3CrN6
362.60
297.03
monoclinic
C2/c
9.0315(6)
14.2944(9)
11.318(1)
90
97.307(1)
90
1449.2(2)
4
1.662
1.337
0.304×0.193×
0.147
9746 /56.662

(2)
C12H18Cl3CrN6
404.67
296.15
orthorhombic
Pna21
17.46(1)
6.801(5)
14.86(1)
90
90
90
1764(2)
4
1.524
1.107
0.1×0.07×0.06

(3)

18160 /53.254

4
1.498
1.088
0.206×0.098×
0.093
30063/52.902

(4)
C9H9Cl6CrN6
465.92
273.15
triclinic
P-1
6.792(3)
10.395(3)
12.218(4)
78.81(2)
89.62(2)
88.19(2)
845.7(5)
2
1.830
1.626
0.199×0.122×
0.081
16370 /52.608

1805/1/115

3704/1/203

3684/0/203

3424/0/244

3678/0/199

6164/0/288

1.132
0.0282/ 0.0728
0.0324/ 0.0763

1.025
0.0272/ 0.0595
0.0359/ 0.0636

1.028
0.0428/ 0.0815
0.0678/ 0.0894

1.045
0.0270/ 0.0629
0.0358/ 0.0669

1.028
0.0366/ 0.0836
0.0515/ 0.0913

1.055
0.0363/ 0.0883
0.0555/ 0.0951

C12H18Cl3CrN6
404.67
273.15
orthorhombic

P212121
11.356(2)
11.590(2)
13.632(3)
90
90
90

1794.2(6)
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(5)
599.30
273.15
monoclinic
P21/c
8.868(6)
9.913(6)
20.66(1)
90
100.47(2)
90
1786(2)
4
2.229
7.803
0.239×0.172×
0.027
28963 /52.952

(6)
C13H17Cl3CrI3N6O
810.47
295
triclinic
P-1
9.5178(8)
10.6190(9)
12.613(1)
78.787(2)
82.592(2)
86.424(2)
1239.1(2)
2
2.172
4.519
0.259×0.094×
0.073
17118 /56.78

C9H9Br3Cl3CrN6

Table 15. Structure refinement parameters for complexes 7 - 8.
Compound
Empirical formula
Formula weight
Temperature/K
Crystal system
Space group
a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
Crystal size/mm3
Reflections
collected/2Θmax(°)
Data/restraints/parameters
Goodness-of-fit on F2
R1, wR2 [I>=2σ (I)]
R1, wR2 [all data]

(7)
C12H16Cl3CrN8
430.68
302.21
triclinic
P-1
8.0428(3)
8.4370(4)
14.9426(6)
76.697(1)
89.927(1)
68.369(1)
913.34(7)
2
1.566
1.077
0.141×0.101×0.096
19464 /52.84

(8)
C16H24Cl3CrN8
486.78
149.63
monoclinic
C2/c
12.8962(9)
13.132(1)
14.185(1)
90
109.644(2)
90
2262.4(3)
4
1.429
0.879
0.36×0.148×0.135
14958 /56.848

3729/0/220
1.099
0.0432/ 0.0898
0.0591/ 0.0965

2839/0/139
1.043
0.0480/ 0.1335
0.0575/ 0.1433
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Table 16. Structure refinement parameters for complexes 9 - 13.
Compound
(9)
(10)
Empirical formula C36H63Cl4Cr3N18O7 C120H180.01Cl24Cr12N60O6
1157.85
4034.19
Formula weight
295
273.15
Temperature/K
cubic
trigonal
Crystal system
Pa-3
P-3c1
Space group
22.6174(3)
21.349(3)
a/Å
22.6174(3)
21.349
b/Å
22.6174(3)
13.788(2)
c/Å
90
90
α/°
90
90
β/°
90
120
γ/°
3
11569.9(5)
5442(2)
Volume/Å
8
1
Z
3
1.329
1.231
ρcalcg/cm
0.794
0.921
μ/mm-1
4808.0
2064.0
F(000)
0.126 × 0.083 × 0.06 0.151 × 0.131 × 0.053
Crystal size/mm3
2Θ range for data
5.974 to 52.702
5.83 to 49.446
collection/°
80864
Reflections collected 187939
Data/restraints/para
3940/0/211
3101/1/173
meters
Goodness-of-fit on
1.147
1.075
F2
0.0662/ 0.1970
R1, wR2 [I>=2σ (I)] 0.0919/ 0.2367
0.0954/ 0.2145
R1, wR2 [all data] 0.1525/ 0.2668

(11)
C100H140Cl20Cr8N48O4
3203.59
273.15
monoclinic
P21/c
14.379(1)
16.118(1)
17.104(1)
90
95.513(2)
90
3945.8(5)
1
1.348
0.925
1640.0
0.126 × 0.083 × 0.059

(12)
C9H11.5Cl1.5CrN6O0.5
316.92
273.15
monoclinic
P21/c
11.4398(9)
15.327(1)
15.813(1)
90
93.818(2)
90
2766.4(4)
8
1.522
1.111
1288.0
0.133 × 0.104 × 0.077

(13)
C72H68Cl36Cr8N48O4
3361.94
273.15
monoclinic
P21/c
14.350(2)
15.959(3)
17.356(3)
90
96.769(5)
90
3947(1)
1
1.414
1.190
1672.0
0.156 × 0.144 × 0.056

5.798 to 49.574

5.808 to 52.902

5.718 to 52.702

60939

53854

82500

6759/0/416

5672/10/366

8001/0/383

1.021

1.030

1.040

0.0597/ 0.1172
0.1134/ 0.1354

0.0563/ 0.1190
0.0978/ 0.1347

0.0494/ 0.1317
0.0713/ 0.1432
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Chapter 3: Chromium mixed-ligand complexes with Cr3(μ3-O) cores
3.

Synthesis of trinuclear chromium mixed-ligand formate-pyrazolate

complexes

3.1.

Introduction
Mixed

pyrazolate-carboxylate

complex

with

formula

[Co3O(μ-OAc)3(μ-

pz)3(pzH)3](PF6) has been previously synthesized and characterized.102 Paramagnetic
shifts in the NMR spectra were not observed as consequence of the diamagnetic nature of
the all LS-Co(III) trinuclear centers. Mixed ligand complexes of cobalt show a reversible
reduction and an irreversible oxidation. Increasing the amount of bridging pyrazolate
ligands in these complexes alters their redox potential.

Scheme 10. Structure of [Co3(μ3-O)(μ-OAc)3(μ-pz)3(pzH)3]-.102

Here we present the synthesis of new chromium mixed-ligand formate-pyrazolate
complexes, their crystal structure, electronic absorption spectra, and NMR studies.
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3.2.

Results and discussion

3.2.1. Synthesis
The use of high boiling point solvent and the use of Cr(NO3)3·9H2O yielded
higher nuclearity complexes. Hydrolysis of DMF and deprotonation of the pyrazole
produced trinuclear formate-pyrazolate mixed-ligand complexes with molecular formula
[CrIII3(μ3-O)(μ-4-Me-pz)3(μ-O2CH)3(DMF)3](PF6)

(14),

[CrIII3(μ3-O)(μ-pz)3(μ-

O2CH)3(DMF)3](PF6) (15), and [CrIII3(μ3-O)(μ-4-Cl-pz)3(μ-O2CH)3(DMF)3](NO3) (16).
Synthetic method was designed from reported chromium carboxylate complex
synthesis.103 Both, the microwave and thermally assisted syntheses produced the
complexes; the latter required longer reaction time. Low yields are characteristic of these
syntheses. The use of Cr(NO3)3·9H2O prevented the formation of mononuclear
complexes with form [mer-CrCl3(pzH*)3].
3.2.2. Crystallographic data
Structures of complexes 14, 15, and 16 were determined by single-crystal XRD;
refinement parameters are summarized in Table 22. Complexes 14 and 15 crystallized
with one third of a molecule in the asymmetric unit, whereas complex 16 crystallized
with a whole molecule in the asymmetric unit. Complexes 13 and 15 crystallized in
trigonal R-3 and P-31c space groups, respectively. Complex 16 crystallized in monoclinic
P21/c space group. The presence of monoanionic counter ion and the Cr···μ3-O bonds
distances are consistent with all CrIII complexes. Complexes 14 and 15 crystallized with
PF6- and complex 16 with NO3- counter ion. Complexes also crystallized with
dimethylamine, product of the hydrolysis of DMF.
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Three six-coordinate chromium centers are bridged by an oxygen atom forming a
Cr3(μ3-O) core. Complexes 14 and 15 have a 3-fold axis though the μ3-O atom. The
Cr3(μ3-O) core is supported by six bridging ligands and three terminally coordinated
DMF molecules. Formate and pyrazolate ligands face opposite directions, causing
structural differences to the all-carboxylate complexes. For all complexes, the average
Cr-N bond lengths in the μ-pyrazolate are shorter than the Cr-O in the μ-formate (Table
17). The addition of pyrazolate bridging ligands shortens the Cr···Cr distance compared
the carboxylate analogs because of the ligand's rigidity differences (Table 18). The central
μ3-O atom slightly protrudes from the Cr3 plane towards the formate ligands in the
mixed-ligand complexes because of their electron deficient properties compared to the
pyrazolate groups. In contrast, in the all-carboxylate trimers, the central μ3-O atom is
located on the Cr3 plane. The distances between μ3-O atom and the Cr3 plane are
0.23460(1), 0.23395(2), and 0.22426(2) Å in 14, 15, and 16, respectively.
Table 17. Selected interatomic distances (Å) for complexes 14 - 16.
Compound
Bond
14
15
16
Cr—μ3-O
1.873(1)
1.874(2)
1.871(8) - 1.883(8)
Cr ···Cr
3.2190(2)
3.2198(3)
3.2235(3) - 3.2372(3)
Cr —N
2.011(5) - 2.031(6)
2.00(1) - 2.03(1)
2.00(1) -2.04 (1)
μ3-O ··· Crplane
0.23460(1)
0.23395(2)
0.22426(2)

Table 18. Cr ···Cr distances (Å) and angles (°) for selected trinuclear chromium
carboxylate complexes.
Complex
[Cr3O(O2CPh)5(H2N-sao)(EtOH)2]
[Cr3O(μ-O2CCH2CH3)6(Hpz)3]+
[Cr3O(μ-O2CPh(OH))7(H2O)2]
[Cr3O(μ-C3H5O2)6(H2O)3]+

Distance (Å)
Cr ···Cr
3.359(1), 3.312(1), 3.210(1)
3.284(1) - 3.305(1)
3.310(2), 3.301(2), 3.294(1)
3.256(1)-3.288(1)
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Angle (°)
Cr—μ3-O
1.905(3)
1.900(6)
1.906(4)
1.891(3)

Ref
104
105
106
107

Figure 41. Ball and stick representation structure of [CrIII3(μ3-O)(μ-4-Me-pz)3(μO2CH)3(DMF)3]+ (14).
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Figure 42. Ball and stick representation structure of [CrIII3(μ3-O)(μ-pz)3(μO2CH)3(DMF)3]+ (15).
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Figure 43. Ball and stick representation structure of [CrIII3(μ3-O)(μ-4-Cl-pz)3(μO2CH)3(DMF)3]+ (16).
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3.2.3. Electrochemistry and absorption spectra
The presence of pyrazolate ligands and the various accessible oxidation states of
chromium lead us to assume that these complexes would have reversible electrochemical
properties, similar to the cobalt(II) analog. Contrary to expectations, trinuclear mixedligand

chromium(III)

complexes

with

formula

[CrIII3(μ3-O)(μ-4-R-pz)3(μ-

O2CH)3(DMF)3]+ (R = Me, H, Cl) showed no reversible processes in the -1 V to 1 V
window in DCM.
The electronic spectra of trinuclear oxo-bridged chromium(III) complexes have
been studied extensively with different acetate ligands. Usually, these exhibit two spinallowed bands corresponding to 4A2g - 4T2g(F) and 4A2g - 4T1g(F) transition, where small
energy shifts are observed from the variation of bridging ligands.108,109 UV-Vis of 14 - 16
shows two allowed transitions with similar energy listed in Table 20. Small energy shifts
are observed from the variation of the pyrazole substitution.

Table 19. Electronic absorption spectral (cm–1) data for trinuclear mixed-ligand acetate
complexes.108
Complex
[Cr3O(OAc)3(OOCC13H27)3](OAc)·3MeOH
[Cr3O(OAc)3(OOCC15H31)3](OAc)·3MeOH
[Cr3O(OAc)3(OOCC17H35)3](OAc)·3MeOH
[Cr3O(SOCPh)3(OOCC13H27)3](OAc)·3MeOH
[Cr3O(SOCPh)3(OOCC15H31)3](OAc)·3MeOH
[Cr3O(SOCPh)3(OOCC17H35)3](OAc)·3MeOH
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Observed transition from 4A2g (F) to
4
4
T2g (F)
T1g (F)
(ν1, 10Dq)
(ν2)
17155
22620
16775
22545
16795
23055
17800
22850
16730
23220
16830
22860

Table 20. Electronic absorption data (cm-1) for 14 - 16.
Complex
[CrIII3(μ3-O)(μ-pz)3(μ-O2CH)3(DMF)3](PF6)
[CrIII3(μ3-O)(μ-4-Me-pz)3(μ-O2CH)3(DMF)3](PF6)
[CrIII3(μ3-O)(μ-4-Cl-pz)3(μ-O2CH)3(DMF)3](NO3)

Observed transition
(ν1, 10Dq)
(ν2)
18587
24096
18248
24154
18518
23980

3.2.4. Nuclear magnetic resonance
There are many examples of trinuclear CrIII carboxylate complexes that are NMR
active due to the intermediate spin relaxation rate that makes their NMR spectra possible
to record. Nuclear magnetic resonance (NMR) has been used to study the chemical
structure and formation mechanisms of assemblies with general formula [CrIII3(μ3-O)(μO2CR)6(L)3]. The octahedrally-coordinated Cr(III) centers in trinuclear complexes, are
paramagnetic with a magnetic moment of 3.14 μB, compared to the calculated 3.87 μB for
mononuclear species.110 Reduction of magnetic moment as a result of antiferromagnetic
coupling between metal centers allows NMR spectra to be observed. Results show that
coordinated bridging acetate ligands have paramagnetically shifted signals compared to
free acetate.95
Spectra for complexes 14 - 16 showed two broad peaks shifted downfield and a
broad peak shifted upfield. Peak integration ratio of 3:1 confirms signals shifted furthest
downfield corresponding to the coordinated DMF methyl groups and the broad peak at
around 1.7 ppm to the H3/H5 proton of the bridging pyrazolate. The disappearance of
peak at 27.7 ppm for complex 14 and appearance of -43.09 ppm for complex 15 confirms
the assignment of the 4-Me and H4 protons, respectively (Figure 45). Spectra of 14 and
15 showed additional peaks attributed to impurities and other synthesis solvents, peak
assignments was supported with spectra of 16 and are listed in Table 21.
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Figure 44. 1H NMR of complex 16 in CDCl3 at 400 MHz. Spectrum referenced to the
residual solvent proton resonance.

Table 21. 1H NMR chemical shifts for complexes 14, 15, and 16 in ppm.
Compound
14
15
16

H3/H5-pzH
1.60
1.78
1.76

Me-DMF
23.01
23.01
22.95

26.18
26.01
26.13
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H4-pzH
-43.09
-

4-Me-pzH
27.70
-

Figure 45. 1H NMR of complex 14 (top) and 15 (bottom) in CDCl3 at 400 MHz. Spectra
referenced to the residual solvent proton resonance.

The extent of paramagnetic shifts in inorganic compounds is determined by the
nature of metal-ligand interaction.83 Shifts might come from either pseudo-contact or
contact shift interactions.84 Similar to the analogous all-carboxylate complexes, the
mixed-ligand pyrazolate-formate CrIII complexes show that contact interactions are the
predominant pathway, which are dominated by electron spin delocalization from the
metal atom to the ligands.110 Spin delocalization can follow the σ (through σ bonds) or π
(through π bonds) mechanisms. Spin delocalization in analogous bridging carboxylate
complexes is known to follows both the σ or π mechanism; with the π mechanism being
the more predominant.111
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Substitution of the methyl group (14) by a proton (15) results in the methyl proton
signal being shifted in the opposite direction of the proton, consistent with a π-spin
delocalization. Similar effect has been observed for the

1

H and

2

H NMR of

[Cr3O(O2CR)6L3] ( R = Me, Ethyl, Ph, 4-Me-Ph and L = H2O, py, 2-Mepy, 3-Mepy, 4Mepy).110 Methyl groups from the coordinated DMF have the longest bond distance to
the metal center and are shifted farthest downfield. Similar behavior is observed for
trinuclear CrIII complexes with picoline ligands, where the magnitude of paramagnetic
shifts show no direct dependence on the bond distance between the metal and ligand.112
Satellite peak at 20.0 ppm should correspond to the remaining proton of the terminally
coordinated DMF molecules, following the σ spin delocalization, while remaining
satellite peak at -22.5 ppm corresponds to proton of bridging formate ligands.
3.3.

Conclusions
The reaction of Cr(NO3)3·9H2O and 4-R-pyrazole (R = H, Me, Cl) in DMF

yielded new trinuclear mixed-ligand pyrazolate-formate CrIII complexes. Solvent served
as a base for pyrazole deprotonation. Solvent are also part of the final product where
DMF molecules are terminally coordinated to the chromium metal centers. Hydrolysis
provided formate bridging ligands and dimethylamine that co-crystallized with the final
product. Paramagnetic complexes were characterized using NMR, where the alternating
chemical shifts on the pyrazole ligand was indicative of delocalization of unpaired
electron density from the metal to the ligands. Mixed-ligand complexes do not show
electrochemical properties due to lability of formate ligands. All-pyrazolate chromium
complexes should be attainable with the use of a non hydrolyzing solvent.
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3.4.

Experimental section

3.4.1. Materials
Chromium nitrate nonahydrate, pyrazole ligands 4-R-pz (R = H, Me, Cl) and
DMF solvent were purchased from Fisher Scientific. All syntheses were carried out using
a CEM Discover SP-Microwave synthesizer, at 130 °C with 100 watts of microwave
power for 10 minutes.
3.4.2. Instrumentation
Refer to section 2.4.2 for details of instrumentation.
3.4.3. Synthesis and characterization
3.4.3.1.

Synthesis of [Cr3(μ3-O)(μ-O2CH)3(μ-4-Me-pz)3(DMF)3]PF6 (14)
A microwave-fitted test tube was charged with 209.1 mg (0.522 mmol) of

Cr(NO3)3·9H2O and 129.2 μL (1.569 mmol) of 4-Me-pzH. Purple solution was obtained
after dissolution of reagents with approximately 1 mL of DMF. Dark pink solution was
obtained after microwave; 202 mg of TBAPF6 were added, followed by addition of water
and extraction with DCM. X-Ray suitable crystals were obtained from hexane layer
diffusion into a DCM solution. 1H NMR (400 MHz, CDCl3)/ppm: δ 1.60 (s, 6H, H3/H5),
23.30 (s, 9H, DMF-Me), 26.18 (s, 9H, DMF-Me), 27.72 (s, 9H, 4-Me).
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3.4.3.2.

Synthesis of [Cr3(μ3-O)(μ-O2CH)3(μ-pz)3(DMF)3]PF6 (15)
A microwave-fitted test tube was charged with 282.2 mg (0.705 mmol) of

Cr(NO3)3·9H2O and 144.2 mg (2.118 mmol) of pyrazole. Purple solution was obtained
after dissolution of reagents with approximately 1 mL of DMF. Reaction was set at 130
°C with 100 watts of microwave power for 10 minutes. Dark pink solution was obtained
after microwave; 136 mg of TBAPF6 were added, followed by addition of water and
extraction with DCM. X-Ray suitable crystals were obtained from diethyl ether diffusion
into a DCM solution. 1H NMR (400 MHz, CDCl3)/ppm: δ -41.22 (s, 3H, H4), 1.78 (s, 6H,
H3/H5), 23.03 (s, 9H, DMF-Me), 26.17 (s, 9H, DMF-Me).
3.4.3.3.

Synthesis of [Cr3(μ3-O)(μ-O2CH)3(μ-4-Cl-pz)3(DMF)3]PF6 (16)
A microwave-fitted test tube was charged with 225.5 mg (0.563 mmol) of

Cr(NO3)3·9H2O and 172.6 mg (1.692 mmol) of 4-Cl-pzH. Purple solution was obtained
after dissolution of reagents with approximately 1 mL of DMF. Pink solution after
microwave was precipitated with diethyl ether and dried in vacuum. X-Ray suitable
crystals were obtained from diethyl ether diffusion into a DCM solution. 1H NMR (400
MHz, CDCl3)/ppm: δ 1.78 (s, 6H, H3/H5), 22.85 (s, 9H, DMF-Me), 26.24 (s, 9H, DMFMe).
3.4.4. Crystal structure
Refer to section 2.4.4 for details on data refinement.
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Table 22. Structure refinement parameters for complexes 14 - 16.
Compound
(14)
C30H60Cr3F6N10O10P
Empirical formula
1021.86
Formula weight
293(2)
Temperature/K
trigonal
Crystal system
R-3
Space group
12.7744(7)
a/Å
12.7744(7)
b/Å
47.259(3)
c/Å
90
α/°
90
β/°
120
γ/°
6678.8(8)
Volume/Å3
5.99994
Z
3
1.524
ρcalcg/cm
-1
0.841
μ/mm
3186.0
F(000)
3
0.219 × 0.13 × 0.09
Crystal size/mm
2Θ range for data collection/° 5.668 to 52.762
27971
Reflections collected
Data/restraints/parameters 3048/6/186
1.124
Goodness-of-fit on F2
0.0831/0.2030
R1, wR2 [I>=2σ (I)]
0.1131/0.2162
R1, wR2 [all data]

(15)
C27H49Cr3F6N10O10P
974.74
150.9
trigonal
P-31c
12.5372(9)
12.5372(9)
28.642(2)
90
90
120
3898.9(6)
3.99996
1.661
0.956
2008.0
0.22 × 0.152 × 0.134
6.5 to 49.446
54327
2231/0/179
1.077
0.0970/0.2354
0.1383/0.2649
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(16)
C21H30Cl3Cr3N10O13
892.90
200.0
monoclinic
P21/c
16.720(1)
20.108(2)
12.920(1)
90
107.880(2)
90
4134.2(6)
4
1.435
1.031
1812.0
0.323 × 0.245 × 0.213
6.258 to 50.054
48299
7256/0/457
1.022
0.0862/0.2175
0.1488/0.2643

Chapter 4: Chromium pyrazolate complexes with Cr3(μ3-O) cores
4.

Pyrazolate-supported Cr3(µ3-O) cores

4.1.

Introduction
The structural parallel between transition-metal carboxylate and pyrazolate

complexes with the same nuclearity have been explored with Pd,29,30 Pt,29 Fe,33 and Cu.113
The metal-core motif of complex remains almost unchanged when one or more bridging
carboxylate ligands are replaced by pyrazolates.102 The electronic structure of a metal
complex along with the metal-to-metal electronic and magnetic communication are
affected by the donor capacity and orbital symmetry of bridging ligands.114
To date, reported chromium(III) carboxylate complexes are not electrochemically
active. Chromium heterocyclic thionates share a similar core structure as the trinuclear
complexes of form [CrIII3(μ3-O)(μ-O2CR)6(L)3], with a μ3-O central core, which show
electrochemical properties.115 Mixed-valent complexes of various transition metals have
been used to determine the vibronic interactions and its effect in double exchange in
complexes of iron, manganese, cobalt and chromium.55 In the case of chromium, mixedvalent carboxylate complex with cyanopyridine affords a d3-d3-d4 configuration, which is
the simplest electronic configuration accessible so far with the Cr3(µ3-O) motif.116
Pyrazolate complexes of chromium with Cr3(µ3-O) cores should have structural
similarities to that of all-carboxylate and electrochemical properties similar to that of
trinuclear thionates.
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Scheme 11. [Cp3Cr3(μ-OH)(μ3-O)(μ-η2-S2CN(C6H4))2]BF4.115

Here we present the synthesis and characterization of the first all-pyrazolate
chromium(III) complexes. This new family of complexes shows reversible oxidation
processes, being the first electrochemically active trinuclear chromium complexes that
access a d3-d3-d2 configuration.
4.2.

Results and discussion

4.2.1. Synthesis and crystal structure
Reaction of Cr(NO3)3·9H2O, 4-Cl-pzH, Et3N, and Ph4PCl in butyronitrile at
100°C results in a pink solution. Pink single crystals of product (Ph4P)2[Cr3(μ3-O)(μ-4Cl-pz)6Cl3] (17) were recrystallized from MeOH slow evaporation or DCM/Et2O vapor
diffusion. One pot synthesis yielded copious amount of green precipitate, which can be
CrCl3

or

[mer-CrCl3(4-Cl-pzH)3].

Reaction

was

optimized

by

heating

the

Cr(NO3)3·9H2O, 4-Cl-pzH, and base until color change, forming an intermediate
trinuclear complex of form [CrIII3(μ3-O)(μ-4-Cl-pz)6X3]. Final compound is produced
after addition of Cl- or Br- terminal ligand, for 17 and 18, respectively.
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Crystallographic structure refinement data for 17 and 18 are listed in Table 25.
Crystal structures of 17 and 18 contain three octahedral CrIII centers bridged by a μ3oxygen atom, forming a Cr3(μ3-O) core, isostructural to the analogous Fe3(μ3-O) core. Six
bridging pyrazolate ligands and three terminal ligands support the Cr3(μ3-O) core.
Complexes 17 and 18 crystallized in a orthorhombic Pbcn space group with half
molecule and a single Ph4P+ counterion in the asymmetric unit. At room temperature
complexes have a 2-fold axis running along the O—Cr—Cl bonds, with two long and one
short Cr···Cr distances and Cr-O bonds listed in Table 23. Both Cr···Cr distance and
Cr—O bond lengths are shorter compared to [Fe3(µ3-O)(μ-4-NO2-pz)6Cl3]2- [3.267(1) and
3.280(1) Å]33 and the reported carboxylate analogs (Table 24). At low temperature, the
symmetry is reduced to Pna21 for 17 and 18. Low temperatures limit the thermal motion
within the structure causing the 2-fold symmetry axis running through the O—Cr—X
[X = Cl (17), Br (18)] to disappear.
Table 23. Selected bond distances (Å) and angles (°) for 17 and 18.
Compound
17

18

Bond
Cr···Cr

293 K
3.198(2)
3.204(1)

100 K
3.2052(6)
3.2172(6)
3.2014(7)

296 K
3.1896(1)
3.2042(1)

150 K
3.203(1)
3.201(1)
3.213(1)

Cr—X

2.323(2)
2.325(2)

2.47753(8)
2.4757(1)

Cr—N

2.034(4)-2.065(4)

2.326(4)
2.322(4)
2.318(4)
2.04(1) -2.08(1)

2.470(1)
2.473(1)
2.475(1)
2.041(6)- 2.072(6)

Cr—O

1.843(4)
1.852(2)

1.864(9)
1.847(7)
1.846(10)

1.84878(7)
1.84643(6)

1.853(4)
1.843(4)
1.858(4)

120.3(1)
119.5(3)

119.21(2)
120.35(1)
120.37(1)

120.264(1)
119.471(3)

120.5(2)
120.2(2)
119.3(2)

Cr—O—Cr
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2.0395(1)-2.0781(1)

Table 24. Cr···Cr (Å) distance for selected all-carboxylate chromium complexes.
Complex
[Cr3O(μ-O2CCH2CH3)6(Hpz)3]+
[Cr3O(μ-O2CCH2CH3)6(H2O)3]+
[Cr3O(μ-O2CCH3)6(H2O)3]+
[Cr3O(μ-O2CH)6(H2O)3]+

Distance (Å)
Cr···Cr
Cr-O(μ3)
3.284(1) - 3.305(1) 1.895(2) - 1.907(2)
3.2863 - 3.289
1.891(3)
3.278(1) - 3.288(1) 1.885(3)- 1.902(4)
3.257(8)
1.881(5)

Ref
105
107
117
118

Figure 46. Ball-and-stick representation [Cr3(μ3-O)(μ-4-Cl-pz)6Cl3]-2(17). Counter ions
are omitted for clarity.

82

Figure 47. Ball-and-stick representation [Cr3(μ3-O)(μ-4-Cl-pz)6Br3]-2 (18). Counter ions
are omitted for clarity.
4.2.2. Electrochemistry
Cyclic voltammogram (CV) and differential pulse voltammogram (PDV) were
collected for complex 17. Since analogous iron pyrazolate complexes have redox
properties and chromium exists in various oxidation states, we expect complex 17 to
show reversible electrochemical processes. The CV of (Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Cl3]
(17) shows a reversible oxidation process for a CrIII3/CrIVCrIII2 species at 0.502 V (Figure
48). The peak-to-peak separation (ΔEp) for this reversible process was 62 mV, which
corresponds to a one-electron† transfer process.119,120 Oxidation potential is similar to that
of [Cp3Cr3(μ2-OH)(μ3-O)(μ2-η2-S2CN(C6H4))2]BF4 (E1/2 = +0.59 V vs Fc+/Fc).115

†

For a reversible process, n (number of electrons) can be calculated from: ΔEp = Epa - Epc ≈ 0.059 / n
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Figure 48. Differential Pulse Voltammogram (DPV) (blue) and Cyclic Voltammogram
(CV) (green) of 17 vs. Fc+/Fc. [Cr3]1-/2- (E1/2 = 0.502 V). 150 mV/s sweep.

Cyclic voltammogram (CV) and differential pulse voltammogram (PDV) of
(Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Br3] (18) are illustrated in Figure 49. An additional
oxidation processes is observed for complex 18. Irregular DPV peaks are suggestive of
irreversible or quasi reversible processes. Two reversible oxidation processes will access
CrIII3/CrIVCrIII2 (E1/2 = 0.332 V) and CrIII3/CrIV2CrIII (E1/2 = 0.584 V) species. The
reduction of potential is indicative that the substitution of Cl- with Br- causes the
oxidation to become easier and a second oxidation process to be accessible.
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Figure 49. Differential Pulse Voltammogram (DPV) (blue) and Cyclic Voltammogram
(CV) (red) of 18 vs. Fc+/Fc. [Cr3]1-/2- (E1/2 = 0.332 V), [Cr3]1-/0(E1/2 = 0.584 V)

Different heights of cathodic and anodic peaks from the CV suggest these
processes are not fully reversible. Differential pulse voltammetry in forward and reverse
(Figure 50), showed both oxidation processes in both directions, indicating that the
processes are not fully reversible in the CV timescale. In the forward DPV, the anodic
sweep confirms both oxidation peaks, with the same height. In the reverse DPV, a
cathodic sweep is applied, and the two peaks are observed with different peak heights,
suggesting that the second oxidation process is not fully reversible.
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Figure 50. CV (red) and DPV (forward, blue; reverse, green) of 18.

4.2.3. Absorption Spectra
Absorption spectra of 17 and 18 shows two broad bands around 18700 cm-1 (υ1)
and 24800 cm-1 (υ2), similar to previously studied trinuclear CrIII pyrazolate-formate
mixed-ligand complexes. These correspond to

4

A2g - 4T2g(F) and

4

A2g - 4T1g(F)

transitions, respectively. Shifts to higher energy on both bands are observed in the allpyrazolate complexes compared to the mixed-ligand complexes. An intense broad band
corresponding to Ph4P+ overlaps with υ2. For pyrazolate complexes, 4A2g - 4T2g(F)
transition is observed at 18690 cm-1 (17) and 18870 cm-1 (18). Energy shifts can be
attributed to the terminal ligand substitution.
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Figure 51. UV-VIS spectra for 17 and 18 in DCM.

4.3.

Conclusions
The use of non-hydrolysable and high boiling point solvent yielded an all-

pyrazolate

complex

with

formula

(Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Cl3]

(17)

and

(Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Br3] (18). Reversible oxidation processes were observed
for both complexes, where the potential depends on the identity of the terminal ligand.
Oxidation potential is reduced from the Cl (17) substituted complex to the Br (18)
substituted complex. Second quasi-reversible oxidation process is observed for 18. These
systems are the first example of electrochemically amendable trinuclear pyrazolate
complex with a {Cr3O} core.
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4.4.

Experimental section

4.4.1. Materials
Chromium nitrate nonahydrate, 4-Cl-pyrazole, Ph4PCl and butyronitrile solvent
were purchased from Fisher Scientific.
4.4.2. Instrumentation
Refer to section 2.4.2 for instrumentation details.
4.4.3. Synthesis
4.4.3.1.

Synthesis of (Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Cl3] (17)
A 10 mL round bottom flask was charged with 235.8 mg (0.590 mmol) of

Cr(NO3)3·9H2O, 181.6 mg (1.780 mmol) of 4-Cl-pzH and 205.5 μL (1.474 mmol) of
Et3N. Reaction mixture was heated to 100°C for 1 hour, until color changed to pink was
observed. To the resulting solution, 443.6 mg (1.164 mmol) of Ph4PCl was added and
heated for 30 minutes. Pink solution was recovered after filtration and solvent was
removed under reduced pressure. Reaction mixture was washed with ethanol followed by
Et2O. X-Ray suitable crystals were obtained from MeOH slow evaporation or DCM/Et2O
vapor diffusion.
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4.4.3.2.

Synthesis of (Ph4P)2[Cr3(μ3-O)(μ-4-Cl-pz)6Br3] (18)
A 10 mL round bottom flask was charged with 201.2 mg (0.503 mmol) of

Cr(NO3)3·9H2O, 154.3 mg (1.513 mmol) of 4-Cl-pzH and 175.5 μL (1.257 mmol) of
Et3N. Reaction mixture was heated to 100°C for 1 hour, until color changed to pink was
observed. To the resulting solution, 420.9 mg (1.003 mmol) of Ph4PBr was added and
heated for 30 minutes. Pink solution was recovered after filtration and solvent was
removed under reduced pressure. Reaction mixture was washed with ethanol followed by
Et2O. X-Ray suitable crystals were obtained DCM/Et2O vapor diffusion.

4.4.4. Crystallographic data
Refer to section 2.4.2 for structure refinement details.
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Table 25. Structure refinement parameters of 17 and 18.
Compound
(17)
Temperature/K
293
100.15
C66H52Cl9Cr3N12OP2 C67H54Cl11Cr3N12OP2
Empirical formula
1566.18
1651.11
Formula weight
orthorhombic
orthorhombic
Crystal system
Pbcn
Pna21
Space group
16.926(2)
23.746(5)
a/Å
17.664(2)
23.746(5)
b/Å
24.054(3)
16.981(4)
c/Å
90
90
α/°
90
90
β/°
90
90
γ/°
3
7191(1)
7073(3)
Volume/Å
4
4
Z
3
1.447
1.551
ρcalcg/cm
-1
0.874
0.967
μ/mm
3180.0
3348.0
F(000)
3
0.198 × 0.078 × 0.052 0.282 × 0.077 × 0.075
Crystal size/mm
5.776 to 49.606
2Θ range for data collection/° 5.724 to 49.626
136294
96314
Reflections collected
12054/1/866
Data/restraints/parameters 6198/21/486
2
1.083
1.058
Goodness-of-fit on F
0.0678, 0.1422
0.0713, 0.1491
R1, wR2 [I>=2σ (I)]
0.1173, 0.1626
0.1207, 0.1685
R1, wR2 [all data]
0.51(6)
Flack parameter
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(18)
296.41
150.15
C67H54Br3Cl8Cr3N12OP2 C67H54Br3Cl8Cr3N11O2P2
1784.49
1786.48
orthorhombic
orthorhombic
Pbcn
Pna21
17.1340(7)
24.040(1)
17.9303(7)
17.8794(8)
24.288(1)
16.9017(7)
90
90
90
90
90
90
7461.6(5)
7264.7(5)
4
4
1.589
1.633
2.415
2.482
3564.0
3568.0
0.24 × 0.113 × 0.112 0.25 × 0.072 × 0.063
5.82 to 52.964
5.894 to 52.938
162357
160232
7708/0/445
14916/1/866
1.200
1.046
0.0804, 0.1573
0.0472, 0.0947
0.1185, 0.1699
0.0707, 0.1035
0.403(9)

Chapter 5: Iron pyrazolate complexes with Fe3(μ3-O) cores
5.

Pyrazolate-supported Fe3(µ3-O) cores

5.1.

Introduction
Spin-crossover (SCO) materials are good candidates for sensing and memory

storage devices.121 External stimulus can cause a SCO transition, where the material
undergoes a change in physical and chemical properties. The reorganization of electron
causes a change in net magnetization, color, and, bond distances. Ligand orientation and
orbital effects on transition metal complexes had been described by Crystal Field
Theory.122 The SCO properties depend greatly on the ligand field surrounding the metal
center. Studies of high nuclearity Fe(II) complexes show a thermally induced
paramagnetic-diamagnetic transition from S=2 to S=0.123,124 In addition, multiple
examples of Fe(II) complexes show reversible SCO processes upon photo-excitation
using UV-Vis or X-Ray radiation.125,126 Spin transition from high-spin (HS) to low-spin
(LS) have been observed at the molecular lever for [MnIII(taa)] [H3taa = tris(1-(2-azolyl)2-azabuten-4-yl)amine] after applying a magnetic field.127 Several other examples
involving mononuclear complexes have been reported.128
The first example of a redox induced spin transition cascade was reported using
trinuclear complex with formula [Fe3(µ3-O)(4-NO2-pz)6(NCS)3]2-. The cascade of HS to
LS electron reorganization arises from the one-electron reduction of the all-ferric
thiocyanate complex to its mixed-valent [Fe3]3- trianionic analogue. This was supported
57

Fe- Mössbauer, 1H-NMR, and UV-Vis-NIR spectroscopy.
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Figure 52. Ball-and-stick representation of [Fe3(μ3-O)(4-NO2-pz)6(SCN)3]2-.

Figure 53. 57Fe- Mössbauer spectra of the all ferric of [Fe3(μ3-O)(4-NO2-pz)6(SCN)3]2(top) and the one electron reduced of [Fe3(μ3-O)(4-NO2-pz)6(SCN)3]3-.

Here we present the synthesis of complexes with formula [Fe3(μ3-O)(4-NO2pz)6L3]2- (L = NCO-, N3-). Iron timers with such ligands are expected to have similar
properties as the reported [Fe3(µ3-O)(μ-4-NO2-pz)6(NCS)3]2- since NCO- and N3- ligands
have similar electron withdrawing properties as SCN-.
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5.2.

Results and discussion

5.2.1. Synthesis and crystal structure description
Reaction of [Fe3(μ3-O)(4-NO2-pz)6Cl3]2- with excess of NaNCO and NaN3
yielded two new complexes with formula [Fe3(μ3-O)(4-NO2-pz)6(NCO)3] (19) and
[Fe3(μ3-O)(4-NO2-pz)6(N3)3] (20). Structures of 19 and 20 contain three octahedral FeIII
centers bridged by a μ3-oxygen; six pyrazolate ligands bridge the iron centers; and each
iron center is bonded to a terminal ligand. The Fe—O bonds and Fe···Fe distances are in
agreement with an all-ferric trinuclear FeIII3 complex. Linear geometry of the terminal
NCO- ligand is consistent with N-bonded NCO.
Complex 19 and 20 crystallized with a whole molecule in the asymmetric unit.
Complex 19 and 20 crystallized in a monoclinic P21/n and P21/C space group,
respectively. Selected bond lengths and crystallographic refinement details are
summarized in Table 26 and Table 28, respectively.

Table 26. Selected bond length for 19 and 20 in Å.
Compound
Bond

19

20

Fe···Fe
Fe-O
Fe-Nterminal

3.266 – 3.271
1.874(3) –1.896(3)
1.947 – 1.966

3.239 – 3.288
1.858(3) – 1.868(3)
1.913 – 2.081
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Figure 54. Ball and stick representation of [Fe3(µ3-O)(4-NO2-pz)6(NCO)3]2- (19). TBA+
counter ion and hydrogen atoms are omitted for clarity.

Figure 55. Ball and stick representation of [Fe3(µ3-O)(4-NO2-pz)6(N3)3]2- (20). Ph4P+
counter ions and hydrogen atoms are omitted for clarity.
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5.2.2. Electrochemistry
Cyclic voltammogram (CV) and differential pulse voltammogram (PDV) were
collected for complexes 19 and 20. Owing to the similarities on electron withdrawing
capacity of NCO and N3, compared to NCS, we expect these complexes to show similar
electrochemical behavior.

Figure 56. CV of 19 vs. Fc+/Fc. of [Fe3(μ3-O)(4-NO2-pz)6(NCO)3]2-/3- (E1/2= -0.70 V)
The CV of (TBA)2[Fe3(µ3-O)(4-NO2-pz)6(NCO)3] (19) and (Ph4P)2[Fe3(μ3-O)(4NO2-pz)6(N3)3] (20) are illustrated in Figure 56 and Figure 57, respectively. Complex 19
shows a one-electron reversible reduction process for a [Fe3(NCO)3]2-/3- species at
-0.70 V. Complex 20 shows a one-electron reversible reduction process at -0.70 V
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corresponding to the reduction pair [Fe3(N3)3]2-/3-. Expected reversible reduction
processes were observed for both complexes at more cathodic potential, -0.70 V, than the
thiocyanate complex (-0.36 V).

Figure 57. DPV (red) and CV (green) of 20 vs. Fc+/Fc. of [Fe3(μ3-O)(4-NO2-pz)6(N3)3]1/2(E1/2= 0.87 V) and of [Fe3(μ3-O)(4-NO2-pz)6(N3)3]2-/3- (E1/2= -0.70 V).

Moreover, an unprecedented reversible oxidation process is observed for 20 at
0.87 V for the oxidation pair [Fe3(N3)3]1-/2-. Simultaneous oxidation and reduction
processes have not been previously observed and it is uncommon for trinuclear
pyrazolate complexes. Compound 20 oxidizes to [Fe3(μ3-O)(4-NO2-pz)6(N3)3]-, a mixedvalent, formally Fe3+2/ Fe4+ species.
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5.2.3. UV-Vis-NIR
All ferric [Fe3(µ3-O)(4-NO2-pz)6(NCO)3]-2 (19) was chemically reduced using
tetrabutylammonium tetrahydroborate (TBABH4). Solution color change was indicative
of reaction. After reaction was filtered, a black solid and orange solution as obtained. The
UV-Vis-NIR of product did not show IVCT band in the NIR region of spectra or any
difference to the UV-Vis of the all-ferric starting material, indicative of a failed reaction.
All ferric [Fe3(µ3-O)(4-NO2-pz)6(N3)3]-2 (20) was chemically reduced using
TBABH4. The UV-Vis-NIR of 20 (Figure 58) shows a blue shift on CT bands after
reduction, consistent with Metal-to-Ligand CT bands. An IVCT band at 9081 cm-1 in the
NIR region of the spectrum (inset) is characteristic of a partially delocalized mixed-valent
species in solution. Band broadness suggests charge delocalization upon reduction,
having all iron centers with the same oxidation state (Fe2.66+). The empirical parameter, Γ,
0.30 was calculated for the IVCT band, typical of a weakly coupled Class II mixed-valent
species.†

†

Parameter is calculated following Hush theory from:

Class I, no interaction, Γ = 0; Class II, weakly coupled, 0 < Γ < 0.5; Class III, strongly delocalized, Γ > 0.5
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Figure 58. UV-Vis- NIR of [Fe3(µ3-O)(4-NO2-pz)6(N3)3]-2 (red) and product of reduction
with TBABH4 (blue).

Chemical oxidization using ammonium cerium(V) nitrate was performed and the
UV-Vis-NIR spectra was recorded (Figure 59). The all ferric (TBA)2[Fe3(µ3-O) (4-NO2pz)6(N3)3] shows two charge transfer band peaks at 22815 cm-1 and 34325 cm-1. After
chemical oxidation, the band at 22815 cm-1 was shifted under the broad band at 36990
cm-1. Expected IVCT band in the NIR was not observed, probably due to the presence or
a charge localized system or incomplete oxidation.
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Figure 59. UV-Vis- NIR of (TBA)2[Fe3(µ3-O)(4-NO2-pz)6(N3)3] (blue), product from
oxidation with ammonium cerium(V) nitrate (green) and bulk electrolysis (orange).

Bulk electrolysis was performed to complex 20 to electrochemically oxidize the
material and study the spectroscopic properties of the product. Electrochemical
measurements are coupled to an in situ spectroscopic measurements in order to probe
intermediates of reaction and/or products.129 Spectra was obtained from a 0.1 M TBAPF6
solution of 20 in DCM, where a 1.25 V potential was applied for 4 hours achieving the
bulk electrolysis of the sample (glassy carbon working electrode, Ag/AgCl reference
electrode, graphite auxiliary electrode). Spectra after bulk electrolysis is consistent with
the spectra obtained after chemical oxidation (Figure 59).
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5.2.4. Infrared spectrum
Characteristic stretch for N3- ligand is obtained from infrared spectroscopy. The
mixed-valent complex obtained from chemical reduction or oxidation can be
characterized as localized, partially localized or delocalized within the three metal
centers. Double stretch in the IR spectrum after chemical oxidation (Figure 60) might be
indicative of charge localization in the IR timescale. Coinciding peak with starting
material at 2059 cm-1 might be indicative of incomplete oxidation. Decrease in stretch
intensity can also suggest terminal ligand substitution with nitrate. Chemical reduction of
20 causes N3- stretch to shift to lower energy, pointing to a bond weakening caused by
additional π back-bonding from the metal to the terminal ligand.
Table 27. IR stretch frequency (cm -1) of coordinated azide ligands.
υ (cm-1)
2059 and 2134
2059
2042

Species
FeIII2FeIV
FeIII3
FeIII2FeII

Figure 60. IR spectra of 20 (blue) and chemical oxidation of 20(green).
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5.2.5. Nuclear magnetic resonance
Previous magnetic studies of trinuclear pyrazolate complexes have determined a
paramagnetic ground state with S=1/2.33 Chemical reduction or oxidation of the trinuclear
complex results in a new diamagnetic ground state S=0. Complex 20 (Figure 61),
reduced, and oxidized product of 20 were characterized using 1H NMR. Broad resonance
at 32.09 ppm corresponds to the paramagnetically shifted proton signal for the H3/H5
position of the pyrazole in 20. After chemical reduction, broad peak at 2.01 ppm is
observed while peak at 32.09 ppm disappears, consistent with a diamagnetic product.
After chemical oxidation, shifted broad band at 30.7 ppm and new signal at 8.62 ppm are
observed, two proton environments after oxidation suggest charge localization on the
mixed-valent FeIII2FeIV system.

Figure 61. 1H NMR of 20 (400 MHz, CDCl3).
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5.2.6.

57

Fe- Mössbauer

Mössbauer spectra were collected from powdered samples of 20 and reduced
product at 80 K. Representative spectra are shown in Figure 62. Spectrum is similar to
other [Fe3(μ3-O)(4-NO2-pz)6L3]2- (L = Cl-, Br-, SCN-, py, 4-Me-py) complexes,
characterized by quadrupole doublets.33–35 The spectra for 20 is highly characteristic of
high-spin ferric ions, with an isomer shift, δ = 0.45 mms-1 and quadrupole splitting ΔEQ =
1.05 mms-1. After chemical reduction a doublet is also observed, suggesting
delocalization of additional electron over the three iron centers. Both, the isomer shift (δ
= 0.40 mms-1) and quadrupole splitting (ΔEQ = 0.83 mms-1) are reduced after chemical
reduction of 20, indicative of an electronic structural change after reduction. The -0.05
mms-1 decrease in isomer shift can suggest a high-to-low spin electronic reorganization as
observed with the [Fe3(SCN)3] complex.34

Figure 62. 57Fe Mössbauer spectra of a powdered sample of 20 (A) and reduced product
(B) at 80 K.
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5.3.

Conclusions

The all-ferric complexes [Fe3(μ3-O)(μ-4-NO2-pz)6L3]2- (L = NCO-, N3) were synthesized
by substitution of terminal Cl- ligands of the parent compound [Fe3(μ3-O)(μ-4-NO2pz)6Cl3]2- using NaNCO and NaN3. Expected reversible reduction processes were
observed for both complexes at more cathodic potential, -0.70 V, than the thiocyanate
complex (-0.36 V). Compound 20 shows a unique reversible oxidation process at 0.82 V
(vs. Fc+/Fc) to [Fe3(μ3-O)(μ-4-NO2-pz)6(N3)3]-, a mixed-valent, formally Fe3+2/ Fe4+
species. Chemical reduction of 19 was unsuccessful, whereas reduction of 20 shows
distinct IVCT band in NIR region of spectra, indicative of mixed-valent specie.
Mössbauer of the reduced product of 20 suggests a high-to-low spin electronic
reorganization similar to the [Fe3(μ3-O)(μ-4-NO2-pz)6(SCN)3] complex.34 Two distinct
signals in 1H NMR and IR spectra after chemical oxidation of 20 suggest incomplete
oxidation or charge localization in a mixed-valent FeIII2FeIV system. Attempts with excess
oxidant have not shown differing results.
5.4.

Experimental section

5.4.1. Materials
Reagent grade chemicals were purchased from Fisher scientific, Aldrich Chemical
Co, Alfa Aesar or ACROS Organics. Pyrazole ligand130 and [Fe3(µ3-O)(4-NO2-pz)6Cl3]2complex33 were synthesized from previously reported methods. Reactions were
performed at room temperature.
5.4.2. Instrumentation
Refer to section 2.4.2 for instrumentation details.
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5.4.3. Synthesis and characterization
5.4.3.1.

Synthesis of (TBA)2[Fe3(µ3-O)(4-NO2-pz)6(NCO)3](19)
A 30 mL vial was charged with 74 mg (0.051 mmol) (TBA)2[Fe3(µ3-O)(4-NO2-

pz)6Cl3], dissolved with 10 mL of DCM, followed by addition of 15.30 mg (2.35 mmol)
of NaNCO. The reaction mixture was stirred for 48 hours. Unreacted NaNCO and NaCl
were filtered as white solid. Single crystals were obtained from hexane layer diffusion
into a DCM solution of product. FTIR (cm-1, solid): 2183.
5.4.3.2.

Synthesis of (TBA)2[Fe3(µ3-O)(4-NO2-pz)6(N3)3 ](20)
A 30 mL vial was charged with 73 mg (0.051 mmol) (TBA)2[Fe3(µ3-O)(4-NO2-

pz)6Cl3], dissolved with 10 mL of DCM, followed by addition of 151.3 mg (2.33 mmol)
of NaN3. Reaction mixture was stirred for 24 hours and then filtered. Red plate single
crystals were obtained from hexane layer diffusion into a DCM solution of product. FTIR
(cm-1, solid): 2059. 1H NMR (400 MHz, CD2Cl2) δ 32.09 (s, H3 and H5).
Complex was also obtained with Ph4P+ counterion using similar condition but
starting with the parent compound (Ph4P)2[Fe3(µ3-O)(4-NO2-pz)6Cl3].Complex was used
for crystal structure determination since TBA+ ions were disordered.
5.4.3.3.

Reduction of (20)
Synthesis was done under inert atmosphere. A 30 mL flash was charged with 81

mg (0.055 mmol) of (TBA)2[Fe3(µ3-O)(4-NO2-pz)6(N3)3] and dissolved in 10 mL of
DCM. To the red solution, 18 mg (0.07 mmol) of TBABH4 was added followed by an
immediate color change to brown. After 40 minutes of stirring, the reaction was filtered.
FTIR (cm-1, solid): 2042. 1H NMR (400 MHz, CDCl3) δ 2.01 (s, H3 and H5).
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5.4.3.4.

Oxidation of (20)
A 25 mL flask was charged with 14.6 mg (0.01 mmol) (TBA)2[Fe3(µ3-O)(4-NO2-

pz)6(N3)3] and dissolved with 10 mL of DCM. To the orange solution, 5.7 mg (0.01
mmol) of [(NH4)2Ce(NO3)6] were added and left to stir for 4 days. FTIR (cm-1, solid):
2134. 1H NMR (400 MHz, CD2Cl2) δ 32.09 and 8.60 (s, H3 and H5).
5.4.4. Crystal structure
Refer to section 2.4.2 for structure refinement details. Disordered DCM solvent
molecule in 20 was resolved by the SQUEEZE instruction.

Table 28. Structure refinement for complexes 18 and 19.
Compound
Empirical formula
Formula weight
Temperature/K
Crystal system

(19)
C53H84Fe3N23O16
1466.98
273.15
monoclinic

(20)
C66H51Fe3N27O13P2
1659.82
293
monoclinic

Space group

P21/n

P21/c

a/Å
b/Å
c/Å
α/°
β/°
γ/°
Volume/Å3
Z
ρcalcg/cm3
μ/mm-1
F(000)
Crystal size/mm3
2Θ range for data collection/°
Reflections collected
Data/restraints/parameters
Goodness-of-fit on F2
R1, wR2 [I>=2σ (I)]
R1, wR2 [all data]

16.174(2)
27.200(3)
17.853(2)
90
90.897(3)
90
7853(2)
4
1.241
0.616
3076.0
0.317 × 0.176 × 0.114
5.618 to 52.958
160914
16121/0/864
0.996
0.0946, 0.1677
0.2437, 0.2171

17.080(3)
16.665(3)
30.856(6)
90
97.43(3)
90
8709(3)
4
1.266
0.599
3392.0
0.426 × 0.324 × 0.142
5.706 to 53.188
104661
17927/0/1000
0.993
0.0746, 0.2022
0.1320, 0.2439
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6.

Conclusions and future work

Chromium pyrazole/pyrazolate:
In order to be able to access materials that would simplify the analysis of
magnetic data of mixed-valent trinuclear and octanuclear iron pyrazolate complexes, the
synthesis of redox active chromium polynuclear complexes was in order. Results are
summarized in Scheme 12. Stable mononuclear complexes of form [mer-Cr3Cl3(pzH*)3]
(pzH*= pzH, 3-Me-pzH, 4-Me-pzH, 4-Cl-pzH, 4-I-pzH, 4-Br-pzH) and [transCr3Cl2(pzH*)4]Cl (pzH* = pzH, 3-Me-pzH) formed from the use of hydrated or
anhydrous chromium chloride salts. Due to intermediate spin relaxation of the
aforementioned mononuclear complexes, they were NMR and EPR active. Variable
temperature NMR was able to elucidate that peaks arise from two pyrazole environments,
pyrazole trans to a pyrazole and pyrazole trans to a chloride. Pyrazole tautomerization
becomes slow at low temperatures, where individual signals are observed for the H3/H5
positions of the pyrazole.
Analogous to iron pyrazolate chemistry, where the reaction of mononuclear
complexes with base yields octanuclear complexes, monomers of chromium were reacted
with base and proven unsuccessful. Trace amounts of trinuclear complex [CrIII3(μ3-O)(μOH)3(3-Me-pzH)9]Cl4 and dinuclear chromium species of formula CrIII2(μ-OH)(μ-4-Mepz)(4-Me-pzH)4Cl2]Cl4] and [CrIII2(μ-OH)(μ-4-R-pz)2(4-R-pzH)4Cl2]Cl] (R = pzH, 4-MepzH, 4-Cl-pzH) are isolated from the mononuclear chromium pyrazole synthesis,
providing the source of complexity in product isolation.
The use of chromium nitrate nonahydrate proved to be efficient in avoiding the
formation of stable complexes of form [mer-Cr3Cl3(pzH*)3] and to obtain higher
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nuclearity complexes. The hydrolysis of DMF accessed new redox inactive trinuclear
mixed-ligand formate-pyrazolate chromium complexes with form [CrIII3(μ3-O)(μ-4-Rpz)3(μ-O2CH)3(DMF)3]- (R = H, Me, Cl). From the obtained complexes, a nonhydrolyzing solvent use was in order to obtain all-pyrazolate complexes.
Thermally assisted synthesis using butyronitrile afforded (Ph4P)2[Cr3(µ3-O)(µ-4Cl-pz)6]2- (X = Cl-, Br-). The two step synthesis produces an intermediate with form
{Cr3(µ3-O)(µ-4-Cl-pz)6X3}2-, where the terminal ligand can be solvent molecules or NO3anions, addition of terminal ligand source affords the final product. Electrochemical
studies of [Cr3(µ3-O)(µ-4-Cl-pz)6Cl3]2- showed a one electron oxidation process at E1/2=
0.502 V, producing a mixed-valent, formally CrIII3/CrIVCrIII2 species. Electrochemical
studies of [Cr3(µ3-O)(µ-4-Cl-pz)6Br3]2- showed two oxidation processes, where the first
process (E1/2 = 0.332 V) became an easier oxidation and a second process (E1/2 = 0.584
V)

became

accessible,

generating

CrIII3/CrIVCrIII2 and CrIII3/CrIV2CrIII species,

respectively.
Iron pyrazolate:
Upon the one electron reduction of [Fe3(µ3-O)(4-NO2-pz)6(SCN)3]2- complex, a
spin cascade is produced, resulting in a HS to LS electronic reorganization of the
complex. To obtain complexes that share similar properties, [Fe3(µ3-O)(4-NO2-pz)6L3]2(L = N3-, CNO-) were synthesized. Electrochemical properties of both complexes were
studies, both showed a reversible one electron reduction at -0.70 V, harder reduction
compared to the SCN- complex (-0.36 V). Most interestingly, [Fe3(µ3-O)(μ-4-NO2pz)6(N3)3]2- showed a unique oxidation process (0.82 V) that can access [Fe3(µ3-O)(μ-4NO2-pz)6(N3)3]-, a mixed-valent, formally Fe3+2/ Fe4+ species.
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Mössbauer data of [Fe3(µ3-O)(μ-4-NO2-pz)6(N3)3]3- is consistent with a all-ferric
complex. After chemical reduction with TBABH4, the single doublet with a reduced
isomer shift (δ = 0.40 mms-1) and quadrupole splitting (ΔEQ = 0.83 mms-1) indicates a
charge delocalization within the complex and a LS species. This experiment is suggestive
of a spin crossover from HS to LS, similar to the previously reported [Fe3(µ3-O)(4-NO2pz)6(SCN)3]2- complex.

Future work
 Further study of terminal ligand effect on electrochemical properties is to follow. Same
reaction conditions and the addition of desired terminal ligand should result in new
complexes (e.g. SCN-, N3-, CN-, py)
 Following up on the redox activity of chromium pyrazolate complexes, chemical
oxidation should afford mixed-valent species. Changes in the UV-Vis-NIR spectra
should be expected, where shifts in CT bands or IVCT would be affected by terminal
ligand identity, as seen for trinuclear pyrazolate complexes.
 Since mixed-ligand formate-pyrazolate complexes were synthesized with the 4-R-pzH
(R = H, Me, Cl), the all-pyrazolate complex with pyrazole and 4-Me-pyrazole should
be obtained with the synthesis method presented here. Studying such complexes would
give insight of the effects of pyrazole substitution on the electrochemical properties.
Such studies are not accessible for trinuclear iron, since complexes are only obtained
with the 4-NO4-pzH ligand.
 Mössbauer spectroscopy of mixed-valent species from chemical oxidation of [Fe3(µ3O)(μ-4-NO2-pz)6(N3)3]1-

is

in

order
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to

elucidate

charge

localization.

Scheme 12. Summary of chromium(III) pyrazole/pyrazolate chemistry.
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Appendix

Figure A.1 1H NMR of complex 14 in CDCl3 at 400 MHz. Spectra referenced to the
residual solvent proton resonance.(* = solvent residue)
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Figure A.2 1H NMR of complex 15 in CD2Cl2 at 400 MHz. Spectra referenced to the
residual solvent proton resonance.(* = solvent residue or impurity)

122

Figure A.3 1H NMR of complex 16 in CDCl3 at 400 MHz. Spectra referenced to the
residual solvent proton resonance.(* = solvent residue or impurity)
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Figure A.4 H1 NMR of reduction of 20. (400 MHz, CDCl3)
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Figure A.5 H1 NMR of oxidation of 20. (400 MHz, CD2Cl2)
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